≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_MELANOMA_EXALLC for full statistics.

Malignant melanoma

EFO Endpoint Browser

C3_MELANOMA

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

4 out of 7 registries used, show all original rules.

183

4. Check minimum number of events

None

183

5. Include endpoints

5796

6. Filter based on genotype QC (FinnGen only)

5796

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF9

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 5796 2847 2949
Unadjusted period prevalence (%) 1.14 0.97 1.30
Median age at first event (years) 63.13 60.03 66.13

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
5265
Matched controls
52649
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
483.8
323.3
320
7
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
835.5
323.3
315
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
21.0
323.0
863
486
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
563.3
323.0
319
6
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
373.5
323.0
649
20
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
1563.0
323.0
1012
8
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
+∞
323.0
311
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
427.3
323.0
361
9
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.8
323.0
1371
2594
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
492.2
323.0
411
9
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.9
323.0
1347
2881
D03.5
ICD-10 Finland
Melanoma in situ of trunk
1390.5
323.0
387
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
600.2
323.0
902
18
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
22.2
323.0
982
539
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
3646.9
323.0
942
*
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
13.0
323.0
1035
972
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
5729.7
323.0
528
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
20.4
323.0
2082
1632
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
4730.3
323.0
445
*
PJA12
NOMESCO Finland
Sentinel node biopsy
14.0
323.0
1699
1728
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
351.6
323.0
644
21
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
11.4
323.0
821
836
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
555.8
323.0
364
7
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
6.6
320.5
903
1597
C43
ICD-10 Finland
Malignant melanoma of skin
1077.3
314.6
305
*
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
790.4
306.4
299
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
4.0
303.7
1485
4751
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
1036.1
302.9
294
*
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
2920.0
299.6
287
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
917.2
269.1
262
*
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
263.8
251
*
S18
ICPC
Laceration/cut
2.7
248.9
2894
16446
C43.51
ICD-10 Finland
Malignant melanoma of the trunk originating in lentigo maligna
278.7
235.5
239
9
180
Kela drug reimbursment
Interferon alfa
103.5
233.5
256
26
L57.0
ICD-10 Finland
Actinic keratosis
4.0
233.2
1090
3256
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
+∞
207.7
198
*
ZZR00
NOMESCO Finland
Flap of skin
9.6
205.9
442
499
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
1021.6
202.4
197
*
S77
ICPC
Malignant neoplasm of skin
17.1
195.8
319
198
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
14.4
194.7
340
251
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
+∞
191.8
183
*
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
+∞
189.7
181
*
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
+∞
188.7
180
*
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
147.6
187.8
199
14
S82
ICPC
Naevus/mole
3.4
178.4
993
3351
C43.73
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip nodular
558.4
165.0
163
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
9.0
165.0
365
431
SPAT1153
SPAT
Removal of sutures
2.3
164.3
2174
12266
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
+∞
162.3
155
*
D22
ICD-10 Finland
Melanocytic naevi
6.2
153.5
443
774
8720/3-C44.3
ICD-O-3
Malignant melanoma, NOS, of skin of other and unspecified parts of face
+∞
152.8
146
*
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
9.9
151.3
316
336
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
380.4
148.8
149
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
76.0
148.5
169
23
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
147.0
148.1
157
11
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
14.7
142.6
246
175
8743/3-C44.5
ICD-O-3
Low cumulative sun damage melanoma of skin of trunk
1407.6
140.2
136
*
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
150.1
138.0
146
10
C43.63
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder nodular
685.5
136.3
134
*
ZZA00
NOMESCO Finland
Split skin graft
5.9
134.4
401
728
TQW99
NOMESCO Finland
Other minor procedure on skin
4.3
130.7
528
1333
C43.30
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face without histology
174.4
130.1
136
8
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
1236.9
124.5
121
*
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
256.0
122.5
125
5
130
Kela drug reimbursment
Malignant tumour
3.1
119.7
736
2609
L03AB05
ATC
interferon alfa-2b; parenteral
26.8
110.2
154
59
L82
ICD-10 Finland
Seborrhoeic keratosis
2.4
110.0
1078
5038
L01XE23
ATC
[U] dabrafenib; oral
1090.6
109.9
107
*
C43.9
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of skin, unspecified
543.9
108.2
107
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
3.3
107.9
592
1924
362
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
107.6
103
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
54.6
107.1
128
24
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
+∞
101.4
97
*
C43.32
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face 'superficial spreading' type
336.7
99.4
100
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
4.8
98.1
345
751
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
5.2
97.4
318
638
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
16.4
94.5
155
97
C43.49
ICD-10 Finland
Malignant melanoma of the scalp and neck other or unspecified histology
319.3
94.2
95
*
3024
Kela drug reimbursment
Dabrafenib and trametinib (adjuvant treatment)
934.7
94.2
92
*
1509
Kela drug reimbursment
Dabrafenib (adjuvant treatment)
934.7
94.2
92
*
8720/3-C44.4
ICD-O-3
Malignant melanoma, NOS, of skin of scalp and neck
934.7
94.2
92
*
JN4BD
NOMESCO Finland
Extensive body CT
2.5
93.3
835
3682
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
4.5
93.1
351
821
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
12.5
92.8
171
141
C43.71
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip originating in lentigo maligna
239.1
91.8
94
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
5.6
90.5
280
527
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
189.2
89.5
93
5
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
14.4
88.6
153
109
C43.90
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin without histology
226.2
86.7
89
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
10.5
85.9
172
168
C43.42
ICD-10 Finland
Malignant melanoma of the scalp and neck: 'superficial spreading' type
+∞
85.6
82
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
85.0
1564
9457
C43.61
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna
293.1
84.9
86
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
83.3
2067
13852
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.1
82.7
341
867
L01XE25
ATC
[U] trametinib; oral
+∞
82.5
79
*
C43.00
ICD-10 Finland
Malignant melanoma of the lip without histology
271.6
78.7
80
*
C43.40
ICD-10 Finland
Malignant melanoma of the scalp and neck without histology
264.4
76.6
78
*
D03.4
ICD-10 Finland
Melanoma in situ of scalp and neck
+∞
76.2
73
*
C69.3
ICD-10 Finland
Malignant neoplasm: Choroid
+∞
76.2
73
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
10.5
73.9
148
145
XQ845
NOMESCO Finland
Dermatoscopy
7.2
72.7
182
259
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
69.1
2095
14681
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.9
67.8
299
806
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
67.1
2446
18016
Z2221
NOMESCO Finland
Medical doctor
1.8
66.9
1517
9691
8720/3-C69.3
ICD-O-3
Malignant melanoma, NOS, of choroid
+∞
64.7
62
*
ZXC50
NOMESCO Finland
Cryotherapy
3.8
64.0
287
785
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
5.4
63.5
199
380
9734
FHL
Excision and local plastic or associated free skin grafting
10.4
62.8
126
124
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
2.6
60.8
472
1897
8720/3-C69.9
ICD-O-3
Malignant melanoma, NOS, of eye, NOS
+∞
59.5
57
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
4.3
59.4
230
550
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
9.0
59.3
129
147
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
4.8
58.2
203
437
8743/3-C44.7
ICD-O-3
Low cumulative sun damage melanoma of skin of lower limb and hip
+∞
57.4
55
*
8743/3-C44.6
ICD-O-3
Low cumulative sun damage melanoma of skin of upper limb and shoulder
+∞
57.4
55
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.9
57.3
374
1349
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
5.3
57.1
180
346
8720/3-C44.2
ICD-O-3
Malignant melanoma, NOS, of external ear
+∞
56.3
54
*
QCE99
NOMESCO Finland
Other excision or repair of lesion of skin of upper limb
12.8
56.0
101
80
JN4AD
NOMESCO Finland
Body CT examination
2.4
56.0
523
2317
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.8
55.4
381
1422
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
5.3
55.1
176
344
C43.74
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip acral
192.0
55.1
57
*
C43.33
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face nodular
543.5
54.6
54
*
C69.39
ICD-10 Finland
Malignant tumor in chorioidea other or unspecified histology
+∞
54.2
52
*
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
13.6
53.6
94
70
L01EC02
ATC
dabrafenib; oral
+∞
53.2
51
*
XQ848
NOMESCO Finland
Dermatological photography
4.0
52.9
225
587
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
4.2
52.8
211
520
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
9.3
52.4
111
121
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
9.4
51.2
108
117
8742/3-C44.9
ICD-O-3
Lentigo maligna melanoma of skin, NOS
502.6
50.5
50
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.8
50.0
349
1312
L01AX03
ATC
temozolomide; systemic
10.9
48.2
94
88
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
48.2
1064
6626
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
48.0
1650
11647
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
4.3
46.2
177
419
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
9.4
46.1
97
105
C43.20
ICD-10 Finland
Malignant melanoma of the outer ear and in the external ear canal without histology
237.0
46.0
47
*
L01EE01
ATC
trametinib; oral
+∞
45.9
44
*
WX110
NOMESCO Finland
Local anesthesy
1.5
45.8
3228
26851
ZXA00
NOMESCO Finland
Right side
1.6
45.6
1490
10345
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.6
45.1
213
608
S29
ICPC
Skin symptom/complaint other
1.8
44.9
899
5409
C43.29
ICD-10 Finland
Malignant melanoma of the outer ear and in the external ear canal other or unspecified histology
+∞
44.8
43
*
JN4CD
NOMESCO Finland
Very extensive body CT
2.8
43.6
296
1093
ZXE00
NOMESCO Finland
One hour or less
1.5
43.4
1972
14793
C43.43
ICD-10 Finland
Malignant melanoma of the scalp and neck nodular
431.1
43.2
43
*
3016
Kela drug reimbursment
Binimetinib and encorafenib
+∞
42.8
41
*
17281
ICD-8 Finland
Malignant melanoma of skin, Lower limb
420.9
42.2
42
*
ZZA50
NOMESCO Finland
Full thickness skin graft
9.7
42.2
87
91
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
3.5
42.1
206
605
1513
Kela drug reimbursment
Binimetinib and encorafenib
+∞
41.7
40
*
J01DB01
ATC
cefalexin; oral
1.6
41.2
4021
35503
C43.4
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of scalp and neck
+∞
40.7
39
*
WX140
NOMESCO Finland
Parabulbar anesthesy
2.6
40.6
308
1215
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
5.5
40.6
124
231
I78.1
ICD-10 Finland
Naevus, non-neoplastic
3.8
40.5
178
479
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.2
40.2
448
2151
S26
ICPC
Fear of cancer of skin
5.7
39.8
118
212
D03.30
ICD-10 Finland
Melanoma in situ on the lip
+∞
39.6
38
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
39.5
483
2412
ZXA05
NOMESCO Finland
Left side
1.6
39.5
1384
9712
WX002
NOMESCO Finland
Sedation and analgesia
1.7
38.8
1061
6973
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
21.3
38.7
57
27
8721/3-C44.9
ICD-O-3
Nodular melanoma of skin, NOS
+∞
38.6
37
*
C43.41
ICD-10 Finland
Malignant melanoma of the scalp and neck originating in lentigo maligna
+∞
38.6
37
*
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
2.6
38.2
290
1144
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
6.5
38.0
101
158
C69.02
ICD-10 Finland
Malignant tumor in conjunctival melanoma
+∞
37.5
36
*
S21
ICPC
Skin texture symptom/complaint
1.8
36.5
659
3813
D06BB10
ATC
imiquimod; topical
2.6
36.2
284
1141
C43.3
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of other and unspecified parts of face
359.7
36.0
36
*
N02BE01
ATC
paracetamol; systemic, rectal
1.6
35.3
4334
39351
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
2.8
35.0
241
897
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
14.2
34.6
59
42
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
4.0
34.1
142
365
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
34.0
388
1877
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
4.2
33.2
131
321
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
3.6
32.9
155
443
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.8
32.5
214
776
8742/3-C44.3
ICD-O-3
Lentigo maligna melanoma of skin of other and unspecified parts of face
+∞
32.3
31
*
D03.2
ICD-10 Finland
Melanoma in situ of ear and external auricular canal
+∞
32.3
31
*
C69.40
ICD-10 Finland
Malignant tumor of ciliary body without histology
+∞
32.3
31
*
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
3.8
32.2
140
374
17261
ICD-8 Finland
Malignant melanoma of skin, Trunk, except scrotum
318.9
31.9
32
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
4.1
31.8
127
315
Z51.5
ICD-10 Finland
Palliative care
2.1
31.7
369
1800
DAB10
NOMESCO Finland
Partial excision of auricle
7.6
31.6
75
100
PJA10
NOMESCO Finland
Exploration of lymph nodes
4.9
31.6
105
216
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
5.7
31.5
92
163
1725D
ICD-9 Finland
Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,MUU TAI TARK MÄÄR]
+∞
31.3
30
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
5.1
30.8
99
197
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
30.4
727
4571
8721/3-C44.5
ICD-O-3
Nodular melanoma of skin of trunk
+∞
30.2
29
*
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
27.5
30.1
41
15
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
27.5
30.1
41
15
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
8.4
29.8
66
79
9733
FHL
Excision of skin change in operating room or anesthesia
4.2
29.7
115
277
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
3.0
29.6
177
603
R4110
NOMESCO Finland
Physiotherapy
1.5
29.6
1301
9499
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.2
29.4
326
1557
JN6AD
NOMESCO Finland
CT of torso and neck
4.6
29.3
104
230
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
5.8
28.7
82
142
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
4.1
28.2
113
282
DAB00
NOMESCO Finland
Excision of lesion of auricle
4.9
28.1
94
196
WX402
NOMESCO Finland
General anaesthesia
1.6
28.0
754
4889
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
8.2
28.0
63
78
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
27.5
725
4674
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.9
27.4
176
630
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
27.3
534
3154
D03.8
ICD-10 Finland
Melanoma in situ of other sites
+∞
27.1
26
*
L03AB04
ATC
interferon alfa-2a; parenteral
15.3
26.8
44
29
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
4.9
26.7
89
185
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
26.3
658
4176
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.0
26.3
157
535
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
5.0
26.1
85
172
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
6.5
26.1
68
105
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
4.1
25.9
104
260
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
5.9
25.7
73
126
C43.89
ICD-10 Finland
Overall malignant melanoma of the skin other or unspecified histology
261.8
25.7
26
*
Z3231
NOMESCO Finland
Registered nurse
1.4
25.6
1331
10004
C43.22
ICD-10 Finland
Malignant melanoma of outer ear and outer ear canal: 'superficial spreading' type
135.6
25.6
27
*
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
3.3
25.5
134
418
H02AB02
ATC
dexamethasone; systemic
1.7
25.3
525
3155
WZC30
NOMESCO Finland
Teaching
1.6
25.2
658
4221
XCK10
NOMESCO Finland
Photography of fundus of eye
1.7
25.0
534
3236
1906B
ICD-9 Finland
Malignant neoplasm of eye, Choroid[MELANOMA CHORIOIDEAE]
+∞
25.0
24
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
3.5
24.8
117
336
TQB05
NOMESCO Finland
Puncture of skin of trunk
5.7
24.8
72
128
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
6.9
24.7
62
91
C43.82
ICD-10 Finland
Overall malignant melanoma of the skin: 'superficial spreading' type
251.3
24.7
25
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
6.7
24.6
63
95
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
7.0
24.3
60
86
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
20.1
24.3
36
18
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
5.5
24.2
72
132
17271
ICD-8 Finland
Malignant melanoma of skin, Upper limb
+∞
24.0
23
*
TQW40
NOMESCO Finland
Remowal of suture of skin
1.9
23.6
353
1902
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
6.0
23.0
64
108
A98
ICPC
Health maint/preventive medicine
1.6
22.7
4734
44757
C43.64
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder acrally
230.9
22.6
23
*
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
7.7
22.5
52
68
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
3.6
21.9
102
291
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
3.2
21.9
115
360
1725A
ICD-9 Finland
Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,MELAN EX LENTIGOMAL]
+∞
21.9
21
*
D03.1
ICD-10 Finland
Melanoma in situ of eyelid, including canthus
+∞
21.9
21
*
8742/3-C44.5
ICD-O-3
Lentigo maligna melanoma of skin of trunk
+∞
21.9
21
*
ZXC15
NOMESCO Finland
Use of photodynamic technique
3.5
21.7
102
293
C43.91
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin originating in lentigo maligna
220.8
21.6
22
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.3
21.5
195
848
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.0
21.3
126
430
S54
ICPC
Skin, Repair/fix-suture/cast/prosth device
2.5
21.0
170
695
C43.80
ICD-10 Finland
Overall malignant melanoma of the skin without histology
210.7
20.6
21
*
TQW40
SPAT
NA
2.5
20.6
164
666
F16
ICPC
Eyelid symptom/complaint
2.1
20.5
231
1112
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
20.2
499
3148
S79
ICPC
Neoplasm skin benign/unspecified
3.0
20.2
117
393
D23.6
ICD-10 Finland
Benign neoplasm: Skin of upper limb, including shoulder
5.8
20.2
57
99
ZZS00
NOMESCO Finland
Rotation flap
13.0
20.1
35
27
L01XE15
ATC
[U] vemurafenib; oral
+∞
19.8
19
*
1727B
ICD-9 Finland
Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,SUPERFICIAL SPREAD]
+∞
19.8
19
*
1725B
ICD-9 Finland
Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,SUPERFICIAL SPREAD]
+∞
19.8
19
*
8720/2-C44.5
ICD-O-3
Melanoma in situ of skin of trunk
105.4
19.6
21
*
C43.92
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin: 'superficial spreading' type
200.7
19.6
20
*
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.0
19.6
115
391
ZQZ00
NOMESCO Finland
Treatment of several skin areas
5.5
19.5
58
107
C44
ICD-10 Finland
Other malignant neoplasms of skin
7.7
19.5
45
59
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
5.2
19.4
60
116
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
5.2
19.1
59
114
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.9
18.8
292
1597
Z3226
NOMESCO Finland
Physiotherapist
1.4
18.8
860
6254
L01EE03
ATC
binimetinib; oral
+∞
18.8
18
*
3770
FHL
Placing a radiating plate on the surface of the eye with additional measures
+∞
18.8
18
*
C69.42
ICD-10 Finland
Malignant tumor of ciliary melanoma
+∞
18.8
18
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
3.5
18.7
87
250
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
3.9
18.6
76
195
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
6.9
18.6
46
67
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.8
18.5
307
1714
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
3.3
18.5
92
278
C44.60
ICD-10 Finland
Malignant tumor of the skin of the upper extremity including the shoulder without histology
15.1
18.4
30
20
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
5.6
18.3
53
95
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
7.3
18.1
43
59
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
18.1
935
6954
CH2S4
NOMESCO Finland
Photography of iris
33.0
17.9
23
7
ZXC20
NOMESCO Finland
Use of chemical agents
2.6
17.8
127
487
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
3.6
17.7
79
219
L01EC03
ATC
encorafenib; oral
95.4
17.6
19
*
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
17.6
407
2522
B01AB05
ATC
enoxaparin; parenteral
1.3
17.5
1461
11769
QB5S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in back
28.9
17.4
23
8
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
6.6
17.3
44
67
TQD05
NOMESCO Finland
Puncture of skin of lower limb
20.9
17.3
25
12
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
6.0
17.2
47
79
CF2S4
NOMESCO Finland
Photography of conjunctiva
12.6
17.1
30
24
E0000UV
ATC
NA
1.3
17.1
1706
14097
S15
ICPC
Foreign body in skin
1.8
17.0
288
1619
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
5.6
17.0
49
88
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
50.1
17.0
20
*
QDE20
NOMESCO Finland
Excision and repair of scar or web of skin of lower limb
13.2
16.9
29
22
QDE00
NOMESCO Finland
Excision of loose skin or fold of skin from lower limb
25.6
16.9
23
9
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.3
16.9
84
255
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
4.5
16.7
59
133
8721/3-C44.7
ICD-O-3
Nodular melanoma of skin of lower limb and hip
+∞
16.7
16
*
C43.2
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of ear and external auricular canal
+∞
16.7
16
*
1725C
ICD-9 Finland
Malignant melanoma of skin, Trunk, except scrotum[MELANOMA MALIGNUM CUTIS TRUNCI,NODULARE]
+∞
16.7
16
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
16.4
1887
15876
WX320
NOMESCO Finland
Spinalanesthesy
1.4
16.4
1047
8069
L91.0
ICD-10 Finland
Hypertrophic scar
3.7
16.3
70
189
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
30.1
16.1
21
7
Z31.5
ICD-10 Finland
Genetic counselling
2.1
16.1
174
827
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
3.4
16.0
77
228
R4120
NOMESCO Finland
Occupational therapy
1.8
15.7
286
1649
TQW80
NOMESCO Finland
Local dermatologic skincare
2.3
15.6
139
602
8000/3-C69.3
ICD-O-3
Neoplasm, malignant of choroid
+∞
15.6
15
*
C43.19
ICD-10 Finland
Malignant melanoma of eyelids including corner of eye or other unspecified histology
+∞
15.6
15
*
L01XE41
ATC
[U] binimetinib; oral
+∞
15.6
15
*
L01XE46
ATC
[U] encorafenib; oral
+∞
15.6
15
*
C43.23
ICD-10 Finland
Malignant melanoma of the outer ear and in the outer ear canal nodular
160.4
15.5
16
*
D06BX02
ATC
ingenol mebutate; topical
2.9
15.3
91
314
S08
ICPC
Skin colour change
1.9
15.2
243
1341
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
2.3
15.2
142
631
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.8
14.9
272
1568
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
7.0
14.8
36
52
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.6
14.8
416
2708
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
4.7
14.8
49
104
C43.09
ICD-10 Finland
Malignant melanoma of the lip other or unspecified histology
56.8
14.8
17
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2.1
14.6
156
738
D03.0
ICD-10 Finland
Melanoma in situ of lip
+∞
14.6
14
*
C69.45
ICD-10 Finland
Melanoma of iris
+∞
14.6
14
*
C69.99
ICD-10 Finland
Malignant tumor in unspecified localization in eye or other unspecified histology
+∞
14.6
14
*
S04
ICPC
Lump/swelling localized
1.6
14.6
367
2322
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
14.6
4181
39236
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.8
14.5
95
348
1727D
ICD-9 Finland
Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,MUU TAI TARK MÄÄR]
150.4
14.5
15
*
8744/3-C44.9
ICD-O-3
Acral melanoma of skin, NOS
150.4
14.5
15
*
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
6.4
14.4
37
58
Z42.0
ICD-10 Finland
Follow-up care involving plastic surgery of head and neck
9.1
14.2
29
32
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
5.2
14.0
43
84
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.6
13.8
61
170
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.4
13.7
120
516
QBA10
NOMESCO Finland
Incision of skin of trunk
3.3
13.7
67
203
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
3.8
13.6
57
152
3779
FHL
Other operations in this group include disc removal
75.3
13.6
15
*
D18.0
ICD-10 Finland
Haemangioma, any site
2.5
13.6
110
454
C51.13
ICD-10 Finland
Melanoma and labium minus
+∞
13.5
13
*
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
13.5
971
7601
C43.12
ICD-10 Finland
Malignant melanoma of eyelids including corner of eye: 'superficial spreading' type
140.3
13.4
14
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
13.8
13.2
22
16
QCE00
NOMESCO Finland
Excision of loose skin or fold of skin from upper limb
40.1
13.1
16
*
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
3.2
13.0
68
216
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
4.5
13.0
45
101
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
12.9
121
541
D03
ICD-10 Finland
Melanoma in situ
50.1
12.8
15
*
TQC05
NOMESCO Finland
Puncture of skin of upper limb
12.3
12.6
22
18
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
4.1
12.5
47
114
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
5.9
12.5
34
58
1726B
ICD-9 Finland
Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,SUPERFICIAL SPREAD]
+∞
12.5
12
*
8743/3-C44.4
ICD-O-3
Low cumulative sun damage melanoma of skin of scalp and neck
+∞
12.5
12
*
8721/3-C44.6
ICD-O-3
Nodular melanoma of skin of upper limb and shoulder
+∞
12.5
12
*
D22.2
ICD-10 Finland
Melanocytic naevi of ear and external auricular canal
9.0
12.2
25
28
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.3
11.9
109
482
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
5.3
11.9
35
66
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
3.9
11.9
47
120
C43.21
ICD-10 Finland
Malignant melanoma of the outer ear and in the external ear canal originating in lentigo maligna
46.7
11.9
14
*
WF002
NOMESCO Finland
Radical radiotherapy
1.7
11.8
243
1456
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
4.8
11.7
38
80
C43.11
ICD-10 Finland
Malignant melanoma of the eyelids including corner of the eye originating in lentigo maligna
65.1
11.6
13
*
C43.93
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin nodular
65.1
11.6
13
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
4.2
11.6
43
104
A02BC02
ATC
pantoprazole; systemic
1.2
11.5
3024
27583
SPAT1211
SPAT
Application of soft bandage
1.5
11.5
392
2670
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
4.2
11.5
42
100
C44.59
ICD-10 Finland
Malignant tumor of the skin on the trunk other or unspecified histology
10.0
11.5
22
22
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.3
11.5
103
452
C43.54
ICD-10 Finland
Malignant melanoma of the torso acral
+∞
11.5
11
*
1726D
ICD-9 Finland
Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,MUU TAI TARK MÄÄR]
+∞
11.5
11
*
8720/2-C44.6
ICD-O-3
Melanoma in situ of skin of upper limb and shoulder
+∞
11.5
11
*
A04AA02
ATC
granisetron; systemic, transdermal
1.7
11.4
261
1612
HA1AA
NOMESCO Finland
X-ray mammography
1.6
11.3
295
1887
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
3.6
11.2
49
137
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
5.9
11.1
30
51
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
4.5
11.1
38
85
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.2
11.1
114
534
S97
ICPC
Chronic ulcer skin
1.6
11.0
255
1583
N02AA05
ATC
oxycodone; systemic
1.4
10.9
676
5152
ELB50
NOMESCO Finland
Total parotidectomy
7.4
10.9
25
34
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.6
10.9
223
3425
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
4.6
10.9
36
78
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
60.1
10.6
12
*
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
3.0
10.6
59
198
A04AA01
ATC
ondansetron; systemic, rectal
1.6
10.6
272
1733
DHB00
NOMESCO Finland
Excision of lesion of external nose
2.9
10.5
61
209
R23
ICD-10 Finland
Other skin changes
3.2
10.5
54
172
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
1.9
10.5
155
838
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
4.3
10.4
37
86
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
5.0
10.4
32
64
1727C
ICD-9 Finland
Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,NODULARE]
+∞
10.4
10
*
1727A
ICD-9 Finland
Malignant melanoma of skin, Lower limb, including hip[MELANOMA MAL CUTIS EXTR INFER,MELAN EX LENTIGOMAL]
+∞
10.4
10
*
8743/3-C44.3
ICD-O-3
Low cumulative sun damage melanoma of skin of other and unspecified parts of face
+∞
10.4
10
*
8720/2-C44.7
ICD-O-3
Melanoma in situ of skin of lower limb and hip
+∞
10.4
10
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
7.7
10.4
23
30
Z42.2
ICD-10 Finland
Follow-up care involving plastic surgery of other parts of trunk
12.0
10.3
18
15
ZX090
NOMESCO Finland
Other technic of radiotherapy
1.9
10.2
136
707
ZXB10
NOMESCO Finland
Medial
4.0
10.2
39
98
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
3.7
10.1
43
118
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
5.2
10.1
30
58
QWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of skin
5.4
10.1
29
54
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1.7
10.0
190
1113
-59
ICPC
Other therap proced/minor surg NEC
2.0
10.0
124
626
ZZS10
NOMESCO Finland
Transposition flap
16.7
9.9
15
9
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
8.7
9.8
20
23
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
5.8
9.6
26
45
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
1.9
9.6
131
688
L03AA04
ATC
NA
6.3
9.5
24
38
C44.70
ICD-10 Finland
Malignant tumor of the skin of the lower extremity including the hip without histology
9.1
9.5
19
21
D31.4
ICD-10 Finland
Benign neoplasm: Ciliary body
15.0
9.5
15
10
-54
ICPC
Repair/fix-suture/cast/prosth device
2.0
9.5
120
612
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
9.5
610
4673
Z00.0
ICD-10 Finland
General medical examination
1.3
9.5
748
5909
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
3.1
9.4
49
158
C44.3
ICD-10 Finland
Malignant neoplasm: Skin of other and unspecified parts of face
4.8
9.4
30
63
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.4
9.4
545
4107
XX7GT
NOMESCO Finland
Selective internal radio therapy (SIRT) with Yttrium
100.2
9.4
10
*
C69.03
ICD-10 Finland
Malignant tumor of conjunctival carcinoma
100.2
9.4
10
*
8742/3-C44.6
ICD-O-3
Lentigo maligna melanoma of skin of upper limb and shoulder
+∞
9.4
9
*
8720/3-C69.0
ICD-O-3
Malignant melanoma, NOS, of conjunctiva
+∞
9.4
9
*
8720/3-C44.8
ICD-O-3
Malignant melanoma, NOS, of overlapping lesion of skin
+∞
9.4
9
*
C43.8
ICD-10 Finland
Malignant neoplasm: Overlapping malignant melanoma of skin
+∞
9.4
9
*
8744/3-C44.7
ICD-O-3
Acral melanoma of skin of lower limb and hip
+∞
9.4
9
*
8720/3-C44.1
ICD-O-3
Malignant melanoma, NOS, of eyelid
+∞
9.4
9
*
JN6CD
NOMESCO Finland
Very extensive CT of torso and neck
12.3
9.3
16
13
S59
ICPC
Skin, Other therap proced/minor surg NEC
2.8
9.3
56
199
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
4.0
9.3
35
87
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
4.6
9.2
30
65
D23
ICD-10 Finland
Other benign neoplasms of skin
2.4
9.2
74
311
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
9.1
77
331
CDC00
NOMESCO Finland
Enucleation of eye
15.6
9.0
14
9
WF004
NOMESCO Finland
Palliative radiotherapy
2.1
9.0
97
467
Z42.4
ICD-10 Finland
Follow-up care involving plastic surgery of lower extremity
7.4
8.9
20
27
A54
ICPC
General and Unspecified, Repair/fix-suture/cast/prosth device
2.3
8.7
74
319
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.0
8.7
110
562
QDE99
SPAT
NA
7.6
8.6
19
25
9801
FHL
Free skin graft
6.1
8.6
22
36
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
5.2
8.6
25
48
ZX050
NOMESCO Finland
Stereotactic radiotherapy
3.2
8.6
43
136
R23.4
ICD-10 Finland
Changes in skin texture
3.0
8.5
49
167
1XC18
NOMESCO Finland
NA
27.5
8.5
11
*
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
4.5
8.4
28
62
C43.02
ICD-10 Finland
Malignant melanoma of lip: 'superficial spreading' type
90.2
8.4
9
*
PXA20
NOMESCO Finland
Extracorporal circulation of lower extremity using heart-lung assist device
90.2
8.4
9
*
WX702
NOMESCO Finland
Supraglottic ventilation device
1.6
8.4
190
1176
ZXA10
NOMESCO Finland
Bilateral
1.3
8.3
808
6552
C51.03
ICD-10 Finland
Melanoma and labium majus
+∞
8.3
8
*
C69.20
ICD-10 Finland
Retina
+∞
8.3
8
*
D01AE16
ATC
amorolfine; topical
1.4
8.3
496
3753
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
3.5
8.2
36
103
QAE99
SPAT
NA
3.4
8.1
37
109
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
3.8
8.1
32
84
S19
ICPC
Skin injury other
1.7
8.1
158
937
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.1
8.0
82
385
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
4.8
8.0
25
52
QBE99
SPAT
NA
3.8
8.0
32
85
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
4.3
8.0
28
66
D48
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other and unspecified sites
5.5
8.0
22
40
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
2.5
8.0
59
238
M01AX05
ATC
glucosamine; oral
1.2
7.9
911
7547
WB501
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of primary tumour
13.0
7.9
13
10
D23.0
ICD-10 Finland
Benign neoplasm: Skin of lip
4.3
7.8
27
63
AA1AD
NOMESCO Finland
CT of head and brain
1.2
7.8
1056
8907
C43.10
ICD-10 Finland
Malignant melanoma of eyelids including corner of eye without histology
45.0
7.7
9
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
3.3
7.7
36
109
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
2.0
7.7
91
455
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
2.1
7.7
84
406
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
2.9
7.6
44
152
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
2.3
7.6
66
288
C44.29
ICD-10 Finland
Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology
8.0
7.6
16
20
QC9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in upper extremities, unspecified
11.8
7.6
13
11
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
1.9
7.6
107
573
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
2.8
7.5
45
161
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.4
7.5
297
2091
L72.1
ICD-10 Finland
Trichilemmal cyst
1.5
7.5
236
1583
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
2.9
7.5
43
148
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2.0
7.5
88
442
K03.64
ICD-10 Finland
Dental calculus supragingival
1.2
7.4
937
7836
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.2
7.4
1441
12589
PJ003
NOMESCO Finland
Adjuvant radiotherapy of neck, clavicle and axilla
80.2
7.4
8
*
C43.81
ICD-10 Finland
Overall malignant melanoma of the skin originating in lentigo maligna
80.2
7.4
8
*
8720/3-C51.9
ICD-O-3
Malignant melanoma, NOS, of vulva, NOS
80.2
7.4
8
*
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.3
7.4
613
4869
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
4.0
7.3
27
67
R60.0
ICD-10 Finland
Localized oedema
1.3
7.3
461
3522
8742/2-C44.3
ICD-O-3
Lentigo maligna of skin of other and unspecified parts of face
+∞
7.3
7
*
PJ5SN
NOMESCO Finland
Sentinell SPECT with low dose CT
+∞
7.3
7
*
C43.1
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of eyelid, including canthus
+∞
7.3
7
*
C69.90
ICD-10 Finland
Malignant tumor in unspecified localization in eye without histology
+∞
7.3
7
*
8721/3-C44.3
ICD-O-3
Nodular melanoma of skin of other and unspecified parts of face
+∞
7.3
7
*
1726A
ICD-9 Finland
Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,MELAN EX LENTIGOMAL]
+∞
7.3
7
*
8742/2-C44.5
ICD-O-3
Lentigo maligna of skin of trunk
+∞
7.3
7
*
QB3S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in abdomen
10.9
7.3
13
12
QCE20
NOMESCO Finland
Excision and repair of scar or web of skin of upper limb
6.8
7.3
17
25
CD2S4
NOMESCO Finland
Photography of eye
3.5
7.2
31
88
D22.0
ICD-10 Finland
Melanocytic naevi of lip
5.1
7.2
21
41
A79
ICPC
Malignancy NOS
2.3
7.2
61
266
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
4.1
7.2
26
64
8720/3-C80.9
ICD-O-3
Malignant melanoma, NOS, of unknown primary site
30.0
7.1
9
*
5702
FHL
Local lymph node removal (eg armpit, groin)
3.9
7.1
27
69
C44.40
ICD-10 Finland
Malignant tumor of the skin of the scalp and neck without histology
4.8
7.1
22
46
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.5
7.1
237
1615
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
4.5
7.1
23
51
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
2.6
7.0
46
175
ELB40
NOMESCO Finland
Partial parotidectomy
2.4
6.9
53
219
XKD00
NOMESCO Finland
Uroflowmetry
1.3
6.9
766
6307
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
6.9
666
5396
WX142
NOMESCO Finland
Sub-tenon anesthesy
3.4
6.9
31
92
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
7.5
6.9
15
20
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
0.6
6.9
75
1333
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
2.2
6.9
67
312
WC325
NOMESCO Finland
Demanding therapy of local tumor recidive with biomodifiers
40.1
6.8
8
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
2.1
6.7
71
343
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
3.3
6.7
31
94
N05AX08
ATC
risperidone; systemic
0.6
6.7
140
2132
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
6.7
111
631
Q82.58
ICD-10 Finland
Congenital non-neoplastic naevus
2.9
6.6
38
132
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
3.4
6.6
29
85
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.5
6.6
231
1593
H35.7
ICD-10 Finland
Separation of retinal layers
2.8
6.5
39
141
QXA05
NOMESCO Finland
Skin division, unspecified location
4.3
6.5
22
51
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
2.6
6.5
43
165
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
1.9
6.5
92
496
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
6.2
6.5
16
26
C69.09
ICD-10 Finland
Malignant tumor in conjunctival other or unspecified histology
69.9
6.4
7
*
QDA10
NOMESCO Finland
Incision of skin of lower limb
2.7
6.4
39
143
L81.9
ICD-10 Finland
Disorder of pigmentation, unspecified
7.4
6.4
14
19
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.6
6.4
153
967
XX1XT
NOMESCO Finland
Other puncture with other radiological guidance
4.4
6.3
21
48
C44.00
ICD-10 Finland
Malignant tumor of the lip skin without histology
8.1
6.3
13
16
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
9.2
6.3
12
13
1726C
ICD-9 Finland
Malignant melanoma of skin, Upper limb, including shoulder[MELANOMA MAL CUTIS EXTR SUPER,NODULARE]
+∞
6.2
6
*
C43.83
ICD-10 Finland
Overall malignant melanoma of the skin nodular
+∞
6.2
6
*
C43.94
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin acrally
+∞
6.2
6
*
8743/3-C44.2
ICD-O-3
Low cumulative sun damage melanoma of external ear
+∞
6.2
6
*
8721/3-C44.4
ICD-O-3
Nodular melanoma of skin of scalp and neck
+∞
6.2
6
*
17241
ICD-8 Finland
Malignant melanoma of skin, Scalp and neck
+∞
6.2
6
*
TNG34
NOMESCO Finland
Major custom moulded orthopaedic cast, knee or lower leg
2.3
6.2
54
238
TPH04
NOMESCO Finland
Cathetrisation of vein
1.2
6.2
869
7335
QXE99
NOMESCO Finland
Other excision or repair of unspecified region of skin
7.0
6.2
14
20
CFA20
NOMESCO Finland
Biopsy of conjunctiva
5.0
6.2
18
36
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
3.2
6.2
29
90
S52
ICPC
Skin, Exc/remov/biopsy/destruc/debrid/caut
5.7
6.1
16
28
L28
ICPC
Limited function/disability (L)
1.2
6.1
668
5491
A99
ICPC
Disease/condition unspecnature/site
1.4
6.1
304
2237
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.5
6.1
218
1507
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.3
6.1
463
3634
NHQ40
NOMESCO Finland
Amputation of toe
2.0
6.0
74
379
N07BA03
ATC
varenicline; oral
0.5
6.0
53
996

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1612
6100
3.28
323.01
7.6
4.1
u/l
238.9
243.8
0.38
1566
5744
(40768804) Tissue Pathology biopsy report
4082
19441
4.72
307.65
3.8
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
2100
6335
4.63
307.65
1.8
1.3
—
—
—
0
0
(4035726)
1479
4408
4.16
307.65
1.5
1.4
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
119
15
80.98
223.71
1.0
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
681
2166
3.43
173.32
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
280
555
5.25
133.65
1.7
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
294
856
3.56
84.46
1.4
1.3
u/l
13.7
11.2
1.94
245
689
(3036481) Cortisol [Moles/volume] in Serum or Plasma
817
4209
2.10
74.75
6.5
2.1
nmol/l
376.7
371.7
0.28
779
3848
(40768795) Lymph node Pathology biopsy report
181
463
4.00
62.62
1.2
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3272
26097
1.58
61.35
9.2
6.3
umol/l
11.6
11.9
0.50
3134
24763
(3013650) Neutrophils [#/volume] in Blood by Automated count
3434
27739
1.58
60.61
11.7
8.9
e9/l
4.1
4.2
3.23
2998
24085
(3044640) Blood type and Crossmatch panel - Blood
2178
15875
1.60
59.71
2.5
2.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
2262
16639
1.59
59.62
7.1
5.8
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4395
37842
1.67
58.03
10.8
7.8
u/l
80.1
79.8
0.13
4152
35532
(3033658) Prothrombin time (PT) actual/Normal
1775
12537
1.60
54.35
4.3
4.0
%
88.2
87.1
1.00
1742
12233
(3006315) Basophils [#/volume] in Blood
2957
23903
1.48
46.03
7.1
5.7
e9/l
0.0
0.0
0.38
2517
20453
(3001604) Monocytes [#/volume] in Blood
2939
23760
1.48
45.52
7.1
5.7
e9/l
0.6
0.6
2.79
2501
20311
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4903
44286
1.70
44.63
18.8
15.2
ml/min/173m2
76.3
76.4
0.13
4287
36793
(3022096) Basophils/100 leukocytes in Blood
2720
21714
1.48
44.53
7.4
6.0
%
0.7
0.7
1.61
2529
20116
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2854
23005
1.47
44.44
4.1
4.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
2992
24368
1.47
44.02
7.2
5.8
e9/l
1.9
1.9
0.20
2587
21205
(3013115) Eosinophils [#/volume] in Blood
3025
24705
1.47
43.77
7.3
5.9
e9/l
0.2
0.2
0.88
2611
21440
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
285
1185
2.48
42.88
1.3
1.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
2782
22450
1.46
42.23
7.6
6.3
%
8.8
8.8
0.03
2599
20865
(3006504) Eosinophils/100 leukocytes in Blood
2768
22328
1.46
42.03
7.4
6.0
%
2.9
2.9
0.34
2578
20672
(3002030) Lymphocytes/100 leukocytes in Blood
2817
22925
1.45
40.07
7.5
6.1
%
27.0
26.9
0.35
2621
21168
(3015377) Calcium [Moles/volume] in Serum or Plasma
2204
17207
1.45
38.70
5.6
3.4
mmol/l
2.4
2.4
1.32
1924
14805
(3018010) Neutrophils/100 leukocytes in Blood
2764
22598
1.43
37.28
7.2
5.9
%
57.9
58.0
0.20
2577
20969
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2846
23395
1.43
37.21
6.5
6.1
mmol/l
1.2
1.2
3.60
2590
21085
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1637
12167
1.48
36.58
2.5
2.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
1628
12191
1.47
34.65
9.2
6.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
5262
49198
1.75
33.10
21.7
19.1
mmol/l
4.0
4.0
4.10
5139
47903
(3019550) Sodium [Moles/volume] in Serum or Plasma
5251
49088
1.74
32.76
21.4
18.9
mmol/l
139.7
139.7
1.06
5139
47884
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3055
25790
1.39
32.26
7.0
6.9
mmol/l
1.2
1.2
3.36
2525
21704
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
132
432
3.10
31.43
1.5
1.4
u/l
32.2
32.8
0.07
124
350
(3021589) Normoblasts [#/volume] in Blood
2548
20962
1.38
30.96
12.0
10.1
e9/l
0.0
0.0
0.96
2091
17070
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5054
46926
1.60
30.62
18.5
16.2
mg/l
24.7
25.5
0.86
4173
37931
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
5291
49713
1.74
30.46
14.1
11.1
u/l
25.7
25.7
0.07
5106
47754
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
56
99
5.70
30.30
1.1
2.0
ug/l
1.7
2.1
0.76
22
54
(3021387) Prolactin [Units/volume] in Serum or Plasma
219
948
2.36
30.14
1.7
1.7
mu/l
291.4
308.8
0.47
206
870
(3018418) pH of Serum or Plasma
1920
15263
1.39
27.89
5.0
4.1
ph
7.4
7.4
0.10
399
2847
(3023323) Follitropin [Units/volume] in Serum or Plasma
266
1289
2.11
27.84
1.3
1.3
iu/l
26.3
33.2
2.95
216
1111
(3007461) Platelets [#/volume] in Blood
5407
51299
1.80
27.63
27.7
23.7
e9/l
244.7
245.1
0.16
5286
49905
(3024731) MCV [Entitic volume]
5407
51310
1.80
27.45
27.6
23.6
fl
91.3
91.5
2.28
5331
50491
(3026361) Erythrocytes [#/volume] in Blood
5407
51314
1.80
27.39
27.7
23.7
e12/l
4.5
4.4
2.28
5277
49739
(3000963) Hemoglobin [Mass/volume] in Blood
5407
51325
1.80
27.22
27.8
23.9
g/l
134.3
134.2
0.20
5336
50515
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1297
9664
1.44
27.20
4.7
3.1
mmol/l
2.5
2.5
0.11
1165
8428
(3010813) Leukocytes [#/volume] in Blood
5406
51321
1.79
27.08
27.7
23.7
e9/l
6.8
6.8
0.07
5275
49733
(3035941) MCH [Entitic mass]
5405
51311
1.79
27.05
27.6
23.6
pg
30.3
30.4
2.66
5329
50492
(40761511) CBC panel - Blood by Automated count
5149
48272
1.60
27.02
16.7
15.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
222
1032
2.20
25.83
1.5
1.8
iu/l
3.8
4.6
0.37
55
350
(3013826) Glucose [Moles/volume] in Serum or Plasma
3378
29636
1.34
24.48
5.7
4.8
mmol/l
6.7
6.8
2.16
3225
27848
(3007853) Bacteria identified in Skin by Aerobe culture
832
5793
1.51
24.37
1.8
1.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
2629
22283
1.33
24.02
6.1
4.9
g/l
35.2
35.0
1.27
2454
20603
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3933
35404
1.34
23.26
4.9
4.0
pmol/l
15.0
14.9
1.72
3523
31821
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
47
91
5.20
23.10
10.6
3.3
u/l
58.4
43.5
0.40
17
30
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4635
42911
1.40
22.27
5.9
4.8
mu/l
1.9
2.2
1.88
4186
38783
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
26
30
8.70
20.64
1.1
1.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1113
8492
1.38
19.51
3.5
3.2
mmol/l
0.8
0.8
0.77
1039
7878
(3031040) Bacteria [#/volume] in Urine by Automated count
3607
32425
1.30
19.42
4.7
4.8
e6/l
1217.2
1805.8
0.24
46
495
(3032080) INR in Blood by Coagulation assay
2522
21677
1.29
19.16
9.6
10.3
inr
1.3
1.3
2.37
704
5977
(3042936) Bacteria identified in Isolate by Culture
965
7216
1.40
19.02
2.0
2.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1833
15171
1.30
18.37
4.0
3.3
u/l
34.8
36.3
0.17
1731
14338
(36304419) Bacteria [Presence] in Urine
1674
13744
1.31
17.66
3.6
3.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
740
5383
1.43
16.91
3.6
3.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
2089
17780
1.27
16.33
4.2
3.9
e6/l
99.7
108.6
0.19
1524
12869
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1870
15763
1.28
15.65
4.5
2.6
u/l
57.5
58.3
0.31
1708
14517
(3030467) Casts [#/volume] in Urine by Automated count
1708
14271
1.28
15.27
3.7
3.3
e6/l
0.4
0.5
0.34
1319
10839
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
298
1838
1.66
14.59
2.9
2.2
ug/l
363.4
639.0
1.24
287
1732
(3002385) Erythrocyte distribution width [Ratio]
4090
37902
1.27
14.57
23.0
19.5
%
13.8
13.8
0.21
4033
37041
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
627
4543
1.43
14.55
2.8
2.4
u/l
33.0
38.4
1.32
551
3881
(3002582) Erythrocytes [#/volume] in Urine
1834
15545
1.26
14.37
3.7
3.4
e6/l
112.5
100.9
0.09
1434
12032
(3009542) Hematocrit [Volume Fraction] of Blood
4406
41273
1.28
13.96
20.0
17.3
%
39.6
39.1
2.66
3015
27321
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1849
15755
1.25
13.68
2.4
2.2
u/l
193.4
219.5
0.79
1741
14706
(3037467) Urinalysis macro (dipstick) panel - Urine
3647
33461
1.24
13.62
4.6
4.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1033
8191
1.32
13.51
3.3
3.1
e6/l
1.7
2.3
2.15
566
4571
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
659
4896
1.39
13.19
1.6
1.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
393
2657
1.51
12.99
3.9
3.2
pmol/l
4.3
4.4
0.59
356
2337
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
383
2576
1.52
12.97
1.3
1.2
iu/ml
136.4
138.4
0.02
92
929
(3017143) Hepatitis C virus Ab [Presence] in Serum
590
4328
1.40
12.71
1.6
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
481
3402
1.45
12.69
2.0
2.1
nmol/l
11.1
12.2
1.96
416
2947
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4842
46064
1.31
12.66
5.3
4.9
mmol/l
6.0
6.0
2.53
4329
41521
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
170
943
1.83
12.18
3.9
3.8
%
57.7
58.1
0.12
170
943
(40768441) Liver Pathology biopsy report
79
330
2.41
12.00
1.2
1.4
—
—
—
0
0
(3013512) EKG study
1769
15191
1.24
11.80
4.4
4.3
—
—
—
0
0
(3044889) 12 lead EKG panel
3693
34229
1.22
11.21
4.5
4.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1445
12263
1.24
10.53
1.4
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1705
14723
1.22
10.53
4.6
4.4
—
—
—
0
0
(3026782) Osmolality of Urine
1220
10223
1.24
9.91
3.1
2.9
mosm/kgh2o
546.8
549.7
0.20
1054
8711
(3021879) Hepatitis B virus core Ab [Presence] in Serum
388
2767
1.43
9.80
1.4
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1219
10234
1.24
9.70
4.8
3.9
ng/l
182.6
491.9
2.52
1011
8497
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
726
5729
1.31
9.62
3.8
4.1
ug/l
8.5
24.3
4.22
566
4724
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1062
8816
1.25
9.32
3.2
2.9
e6/l
1.7
1.1
0.53
596
5152
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
32
95
3.38
9.15
1.2
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
443
3281
1.38
8.99
1.6
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
3801
35638
1.19
8.98
4.2
4.2
mm/h
12.8
13.4
1.77
3476
32741
(40768793) Breast Pathology biopsy report
165
996
1.68
8.90
1.3
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1281
10934
1.22
8.58
3.4
3.2
ug/l
0.8
0.8
0.04
952
7703
(3000494) Fungus identified in Specimen by Culture
712
5692
1.29
8.51
1.4
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1532
13326
1.20
8.41
3.0
2.8
umol/l
5388.1
5243.2
0.04
1317
11390
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4904
47222
1.25
8.38
5.3
5.2
mmol/l
2.7
2.7
0.24
4413
42990
(3020779) Urea [Moles/volume] in Serum or Plasma
621
4890
1.30
8.33
8.2
7.1
mmol/l
10.7
10.6
0.18
597
4639
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
196
1257
1.58
8.32
2.9
2.3
%
195.2
199.4
0.26
185
1197
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2202
19818
1.18
8.14
2.2
2.2
nmol/l
80.0
78.8
1.19
1917
17523
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4761
45741
1.23
8.05
4.7
4.6
mmol/l
1.5
1.5
0.25
4282
41559
(3000850) Epithelial cells [#/volume] in Urine
1278
10967
1.21
8.04
2.9
2.7
e6/l
4.6
5.0
0.59
1132
9595
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4796
46116
1.23
8.03
4.7
4.7
mmol/l
4.6
4.6
0.04
4341
42203
(3003458) Phosphate [Moles/volume] in Serum or Plasma
835
6853
1.26
8.01
6.9
5.8
mmol/l
1.0
1.0
0.33
780
6332
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
698
5612
1.28
7.96
2.9
2.7
umol/l
9.3
9.0
0.13
610
4911
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4614
44230
1.21
7.76
4.2
4.2
mmol/l
1.3
1.3
0.13
4106
39831
(1617658) Protocol used for examination of sentinel lymph nodes
72
350
2.07
7.74
1.1
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1825
16243
1.18
7.57
3.1
3.1
ng/l
1661.4
1609.3
0.13
1565
14102
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
206
1371
1.52
7.45
2.4
2.0
%
91.3
89.7
0.41
195
1291
(3018677) aPTT in Platelet poor plasma by Coagulation assay
980
8247
1.23
7.44
2.1
2.0
s
30.3
29.9
1.13
946
8001
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
276
1950
1.44
7.39
3.1
3.4
u/ml
1901.5
2781.1
0.20
242
1661
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
771
6332
1.25
7.33
5.0
4.8
%
33.2
32.9
0.37
503
4210
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
334
2450
1.39
7.23
4.9
3.9
mmol/l
24.2
24.1
0.25
306
2189
(3014111) Lactate [Moles/volume] in Serum or Plasma
590
4702
1.28
7.21
6.1
6.6
mmol/l
1.4
1.4
0.25
570
4505
(40761536) Microorganisms panel - Urine sediment
517
4050
1.30
7.21
4.5
4.2
—
—
—
0
0
(3036489) Thrombin time
248
1726
1.46
7.21
2.3
1.9
s
21.5
21.7
0.23
228
1527
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
380
2852
1.36
7.13
7.8
8.8
mmol/l
24.4
24.3
0.62
361
2641
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
222
1516
1.48
7.11
1.6
1.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
151
2339
0.64
6.99
3.8
5.1
%
0.8
0.9
0.51
140
2190
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
64
311
2.07
6.93
2.4
2.3
e6/l
542.4
594.3
0.22
19
139
(3000991) Gas panel - Venous blood
552
4391
1.28
6.84
8.2
8.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
76
396
1.93
6.79
5.3
4.8
u/ml
91.0
69.8
0.14
24
112
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
154
2359
0.64
6.78
3.6
5.1
%
1.5
1.6
0.67
141
2210
(3022145) Colonoscopy Study observation
665
5456
1.25
6.36
1.3
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1141
9887
1.19
6.30
5.3
4.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
57
279
2.05
6.10
6.1
6.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
531
4285
1.26
5.87
5.1
4.0
mmol/l
1.2
1.2
0.55
470
3742
(3019150) Specific gravity of Urine by Refractometry
898
10461
0.83
5.86
4.0
4.3
kg/l
1.0
1.0
0.09
127
1600
(3052851) Hemolysis interference index of Serum or Plasma
222
1579
1.42
5.81
3.3
3.5
—
—
—
0
0
(3019225) pH of Specimen
648
5362
1.23
5.73
4.5
4.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
144
944
1.54
5.68
4.7
5.4
iu/ml
634.3
2975.1
0.70
23
146
(46235355) HIV 1 and 2 tests - Meaningful Use set
675
5617
1.23
5.66
1.6
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
499
4020
1.26
5.60
4.2
3.8
ng/l
106.5
94.7
1.36
430
3423
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4574
44144
1.17
5.57
6.3
6.3
mmol/mol
40.1
40.4
1.89
4128
40442
(21494815) CD4 cells/100 lymphocytes in Specimen
67
360
1.87
5.53
1.6
2.2
%
39.5
40.3
—
6
46
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2169
19938
1.14
5.37
4.1
3.9
ng/l
43.3
89.5
1.20
1626
14717
(3008152) Bicarbonate [Moles/volume] in Arterial blood
268
3548
0.74
5.28
7.0
6.8
mmol/l
25.0
24.6
0.99
247
3309
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
212
1527
1.40
5.20
2.0
2.3
g/l
0.0
0.0
0.38
182
1381
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
116
740
1.58
5.19
2.8
2.5
u/ml
162.4
2246.0
—
5
56
(3014576) Chloride [Moles/volume] in Serum or Plasma
792
6754
1.20
5.17
7.5
6.8
mmol/l
104.4
104.4
0.13
785
6595
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
59
312
1.90
5.14
1.6
1.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2080
19142
1.14
4.95
5.8
5.3
ug/l
3.5
3.7
0.08
1826
17028
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
284
2164
1.33
4.91
2.6
3.9
u/ml
38.4
68.1
1.99
273
2078
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
250
1870
1.35
4.89
2.5
2.4
g/l
1.0
1.0
0.07
203
1595
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
835
7198
1.19
4.82
2.9
2.6
%
22.1
22.3
0.13
737
6072
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
222
1637
1.37
4.76
2.0
2.3
g/l
0.0
0.0
1.96
192
1485
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
205
1501
1.38
4.61
2.1
2.4
g/l
0.0
0.0
0.00
181
1377
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2313
21518
1.12
4.49
2.1
2.1
pmol/l
94.6
94.3
0.12
1186
11218
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
582
4888
1.21
4.47
2.1
2.2
g/l
0.2
0.2
2.49
541
4542
(3018572) Chloride [Moles/volume] in Blood
79
1267
0.62
4.40
5.1
6.9
mmol/l
105.5
105.0
0.49
69
1134
(3039000) Anion gap in Blood
79
1266
0.62
4.38
5.1
6.9
mmol/l
11.1
11.2
0.09
69
1133
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
228
1714
1.34
4.36
2.0
2.2
g/l
37.7
37.4
0.34
189
1451
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
85
527
1.62
4.34
1.3
1.2
u/l
53.7
60.4
0.45
57
350
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
996
8782
1.16
4.34
1.8
1.9
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
99
637
1.56
4.34
1.7
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
878
7678
1.17
4.25
2.8
2.5
g/l
2.3
2.3
0.78
817
7086
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
182
1328
1.38
4.21
1.1
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
119
1729
0.68
4.17
4.3
6.2
mmol/l
1.4
1.3
0.38
102
1527
(3014765) Yersinia sp identified in Stool by Organism specific culture
182
1334
1.38
4.11
1.2
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3118
29613
1.11
4.04
3.2
3.2
u/l
53.1
53.0
0.01
2850
27185
(3024869) Neuronal Ab [Presence] in Serum
23
92
2.51
4.04
1.2
1.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
72
438
1.65
3.99
1.3
1.3
u/l
10.6
12.5
0.74
65
402
(42529406) Shigella sp [Presence] in Stool by Culture
182
1342
1.37
3.97
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
255
1977
1.30
3.96
2.7
2.9
u/ml
0.3
0.3
0.19
153
1135
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
98
644
1.53
3.94
2.0
2.3
u/ml
90.9
782.2
0.88
98
626
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
326
2612
1.26
3.91
1.9
1.7
g/l
1.5
1.6
1.06
279
2244
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
161
1168
1.39
3.89
1.6
1.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
168
1228
1.38
3.88
3.8
2.9
mg/l
1.7
1.7
0.57
159
1115
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2675
25247
1.11
3.80
2.5
2.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
142
1016
1.41
3.73
1.2
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
262
2056
1.29
3.73
2.1
2.4
g/l
3.1
3.1
0.05
197
1595
(3020630) Protein [Mass/volume] in Serum or Plasma
547
4659
1.19
3.64
2.9
2.6
g/l
65.9
66.1
0.29
491
4197
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
124
872
1.43
3.60
4.6
3.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
107
734
1.47
3.54
1.5
1.4
u/ml
111.0
121.2
0.40
21
152
(3049717) Cytology report of Urine Cyto stain
285
2277
1.26
3.53
2.8
2.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
66
407
1.63
3.52
1.2
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
97
654
1.49
3.50
1.5
1.5
e6/l
68498.0
69425.3
0.01
55
390
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
145
1055
1.38
3.48
1.3
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
101
694
1.46
3.34
2.0
2.1
mg/l
27.1
25.6
0.09
26
165
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
11
32
3.44
3.33
1.0
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
59
2.72
3.31
4.9
5.4
—
—
—
0
0
(3036603) Volume of Urine
57
346
1.65
3.26
1.5
1.7
ml
2197.7
1829.0
—
7
90
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
182
1388
1.32
3.25
1.6
1.5
g/l
1.2
1.2
0.36
173
1310
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
115
816
1.42
3.22
1.3
1.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
15
55
2.73
3.15
1.1
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1363
12512
1.12
3.13
1.6
1.6
nmol/l
20.6
20.2
0.41
1139
10624
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
118
847
1.40
3.11
1.5
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1153
10497
1.12
3.06
1.8
1.7
mg/l
1.5
1.3
0.42
910
8113
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
74
488
1.52
3.02
1.3
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
23
106
2.17
3.02
1.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
86
586
1.47
3.00
4.4
4.3
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
15
57
2.64
2.96
6.0
5.0
ug/min
83.1
56.6
0.46
15
48
(3027945) Reticulocytes/100 erythrocytes in Blood
717
6351
1.15
2.93
2.7
2.4
%
1.8
1.8
0.30
628
5588
(3019060) Gas panel - Arterial blood
311
3748
0.82
2.93
4.0
4.7
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
102
724
1.42
2.89
1.6
1.5
e6/l
1727.5
2131.3
0.47
75
525
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
104
741
1.41
2.88
1.1
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
130
962
1.36
2.88
1.3
1.3
e6/l
10.9
22.0
0.91
98
742
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
130
963
1.36
2.86
1.3
1.4
e6/l
401.5
1163.0
1.26
105
784
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
270
2203
1.24
2.84
2.1
2.4
g/l
3.6
3.8
3.00
197
1564
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
270
2206
1.23
2.81
2.1
2.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
840
7542
1.13
2.80
27.4
27.9
inr
1.3
1.4
0.66
90
1062
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
270
2208
1.23
2.79
2.1
2.4
g/l
7.2
7.5
1.64
204
1630
(3017569) Oxygen content in Arterial blood
12
299
0.40
2.74
1.3
2.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
334
2800
1.20
2.71
1.3
1.3
au/ml
53.0
54.0
0.02
14
124
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
45
271
1.67
2.70
1.2
1.1
nmol/l
3.9
12.0
0.82
12
63
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
98
701
1.40
2.68
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
107
1455
0.73
2.68
4.0
4.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
20
92
2.18
2.66
1.2
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
913
8267
1.12
2.65
2.8
2.5
umol/l
12.4
12.6
0.20
844
7629
(3003434) Protein [Mass/volume] in Pleural fluid
113
830
1.37
2.65
1.7
1.5
g/l
31.6
31.8
0.07
103
749
(3023520) Reticulocytes [#/volume] in Blood
551
4827
1.16
2.64
2.8
2.5
e9/l
69.0
68.7
0.05
386
3685
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
49
304
1.62
2.64
1.2
1.1
mg/l
50.0
42.2
0.46
38
256
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2084
19684
1.09
2.62
3.0
2.9
ug/l
147.3
145.9
0.07
1887
18009
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
54
344
1.58
2.61
1.2
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
13
306
0.42
2.61
1.3
2.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
251
2055
1.23
2.59
2.1
2.4
g/l
10.0
10.2
0.44
203
1716
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
64
425
1.51
2.58
1.4
1.4
u/l
13.6
13.1
0.18
59
407
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
50
314
1.60
2.57
1.8
1.6
u/l
10.9
6.6
0.36
28
149
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
43
260
1.66
2.56
1.3
1.1
u/l
27.0
33.7
0.34
34
197
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
43
260
1.66
2.56
1.3
1.1
u/l
84.2
91.8
0.21
37
201
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
726
6497
1.13
2.56
7.8
7.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
89
632
1.41
2.56
1.7
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
86
607
1.42
2.55
1.3
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
68
459
1.49
2.54
1.3
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
35
201
1.75
2.51
2.5
2.7
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
47
735
0.64
2.50
2.4
2.4
mmol/l
105.9
105.5
0.24
47
726
(3041354) Potassium [Moles/volume] in Venous blood
47
735
0.64
2.50
2.4
2.4
mmol/l
4.1
4.1
0.07
47
726
(40768800) Prostate Pathology biopsy report
163
1276
1.29
2.48
1.2
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
46
721
0.64
2.48
2.4
2.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
79
1109
0.71
2.43
1.1
1.1
u/ml
6.1
7.9
—
8
107
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
362
3090
1.18
2.43
2.5
2.4
au/ml
35.5
23.5
0.65
15
132
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1638
15359
1.09
2.40
4.6
4.6
%
22.0
22.0
0.04
890
8021
(1002224) Polysomnography panel
190
1525
1.25
2.37
1.1
1.1
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
31
175
1.78
2.37
1.1
1.3
ug/l
15.7
442.3
1.38
14
92
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
274
2287
1.21
2.37
2.1
2.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
40
243
1.65
2.37
2.9
2.5
ml
1820.3
1887.2
0.16
33
210
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
239
1968
1.22
2.36
2.0
1.8
u/l
40.5
38.7
0.62
212
1701
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
677
6068
1.13
2.34
1.7
1.8
—
—
—
0
0
(4027681)
37
222
1.67
2.30
1.4
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
629
5623
1.13
2.27
1.4
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
57
381
1.50
2.27
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
187
0.37
2.26
1.1
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
35
208
1.69
2.26
1.1
1.6
ug/l
2.6
4.5
0.71
24
161
(3003327) Ova and parasites identified in Stool by Light microscopy
164
1304
1.27
2.24
1.5
1.7
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
90
658
1.37
2.23
1.5
1.4
mu/l
36.5
56.7
1.27
77
582
(3004809) Band form neutrophils/100 leukocytes in Blood
119
909
1.32
2.21
3.3
3.6
%
1.1
1.5
0.95
94
693
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
46
295
1.56
2.21
1.1
1.1
mg/l
361.6
289.7
0.75
37
255
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
144
1133
1.28
2.15
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
144
1133
1.28
2.15
1.3
1.3
—
—
—
0
0
(43055459) Dabigatran [Mass/volume] in Serum or Plasma
6
14
4.29
2.15
1.7
1.2
ug/l
106.2
130.0
—
6
7
(40768797) Stomach Pathology biopsy report
758
6880
1.12
2.13
1.3
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
34
205
1.66
2.10
1.3
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
131
1024
1.29
2.07
1.5
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
46
690
0.66
2.07
2.2
2.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
74
532
1.40
2.05
1.2
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
37
230
1.61
2.04
1.1
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
92
686
1.35
2.04
2.2
2.3
pg
33.8
32.7
1.89
92
681
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
119
921
1.30
2.04
1.8
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
56
383
1.47
2.03
1.2
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
669
6051
1.12
2.01
1.7
1.8
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
9
32
2.82
2.00
5.2
3.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
23
126
1.83
1.97
4.9
5.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
53
361
1.47
1.97
1.1
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
142
1130
1.26
1.97
1.3
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
99
752
1.32
1.95
1.2
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
153
1230
1.25
1.95
1.3
1.2
titre
371.7
98.9
0.61
12
90
(3002179) Metamyelocytes/100 leukocytes in Blood
436
3849
1.14
1.94
3.9
4.0
%
0.6
0.6
0.06
113
911
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
34
210
1.62
1.94
1.4
1.3
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
9
33
2.73
1.93
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
60
421
1.43
1.92
1.3
1.5
nmol/l
0.3
0.3
0.13
48
317
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
250
2118
1.19
1.90
1.8
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
115
896
1.29
1.90
1.3
1.3
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
15
72
2.09
1.86
2.3
1.7
pmol/l
39.3
41.6
0.04
15
56
(40759836) Histone Ab [Presence] in Serum by Immunoblot
46
309
1.49
1.84
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
46
309
1.49
1.84
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
75
552
1.36
1.84
1.9
1.8
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
6
17
3.53
1.83
1.0
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
148
1195
1.24
1.83
3.5
3.9
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
46
310
1.49
1.82
1.1
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
83
622
1.34
1.82
1.1
1.1
g/l
1.4
1.5
3.28
77
553
(3004716) Salmonella sp identified in Stool by Organism specific culture
228
1926
1.19
1.80
1.2
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1400
13185
1.08
1.80
2.2
2.3
mg/l
3.0
3.0
0.14
1184
11217
(3041806) Other cells [#/volume] in Blood by Manual count
9
35
2.57
1.80
1.8
1.5
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
7
23
3.05
1.80
1.1
1.0
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
8
29
2.76
1.79
2.3
2.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
135
1083
1.25
1.78
2.8
2.8
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
13
60
2.17
1.77
1.1
1.5
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
46
312
1.48
1.77
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
46
312
1.48
1.77
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
46
312
1.48
1.77
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
33
208
1.59
1.76
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
48
329
1.46
1.76
2.9
3.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
451
4028
1.13
1.71
4.3
4.1
%
0.1
0.2
0.14
135
1190
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
47
323
1.46
1.71
1.3
1.3
mmol/l
11.3
11.7
0.13
21
96
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
37
242
1.53
1.70
1.2
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
14
68
2.06
1.70
11.4
13.7
mmol/l
4.3
5.4
1.45
14
68
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
427
4783
0.88
1.69
1.7
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
56
399
1.41
1.68
2.3
2.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
139
1128
1.24
1.67
1.3
1.3
mg/l
552.2
543.6
0.09
130
1060
(3048689) Calprotectin [Mass/mass] in Stool
552
4997
1.12
1.67
2.2
2.2
ug/g
144.7
153.0
0.16
431
3894
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
76
571
1.34
1.66
1.4
1.3
u/l
443.0
345.2
0.69
76
542
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
6
19
3.16
1.66
1.7
2.1
mg/l
4.6
3.2
—
6
19
(3005322) IgE [Units/volume] in Serum or Plasma
297
2585
1.16
1.65
1.2
1.3
u/ml
132.6
215.6
2.83
275
2363
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
14
69
2.03
1.64
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
224
1908
1.18
1.64
2.2
2.7
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
151
1242
1.22
1.61
1.4
1.2
titre
362.0
978.2
—
5
39
(3025159) Blasts/100 leukocytes in Blood
421
3763
1.13
1.59
4.2
4.1
%
0.1
0.3
0.75
120
992
(3008295) Osmolality of Serum or Plasma
69
515
1.34
1.59
1.3
1.3
mosm/kgh2o
282.8
278.2
1.09
59
393
(44786800) Granulocytes/100 leukocytes in Body fluid
15
77
1.95
1.59
1.5
1.3
%
30.5
20.7
—
9
52
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1058
11287
0.92
1.58
1.7
1.7
pmol/l
24224789.1
33431196.1
0.21
838
9237
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
7
26
2.69
1.58
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
138
1128
1.23
1.57
1.4
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
433
3889
1.12
1.52
2.8
2.4
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
26
161
1.62
1.52
2.0
1.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
470
4243
1.12
1.51
4.3
4.1
%
1.0
0.9
0.16
146
1275
(3051611) Lipemic interference index of Serum or Plasma
72
546
1.32
1.51
3.9
3.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
41
283
1.45
1.49
1.2
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
15
79
1.90
1.49
1.3
1.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
15
79
1.90
1.49
1.1
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
22
131
1.68
1.49
2.5
1.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
72
548
1.32
1.47
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
21
124
1.70
1.46
1.0
1.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
7
28
2.50
1.45
8.0
5.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
46
638
0.72
1.44
1.2
1.4
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
5
16
3.13
1.44
1.0
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
50
361
1.39
1.44
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
50
361
1.39
1.44
1.3
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1343
12735
1.07
1.43
1.6
1.6
mmol/l
1.3
1.3
0.17
1082
10601
(3009445) Proteinase 3 Ab [Units/volume] in Serum
250
2178
1.15
1.42
1.6
1.6
u/ml
5.1
21.1
—
10
54
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
50
362
1.38
1.42
1.3
1.4
—
—
—
0
0
(3016750) Collection duration of Urine
44
312
1.41
1.40
2.6
2.0
min
481.0
490.3
0.22
32
227
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
50
363
1.38
1.40
1.3
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
14
74
1.89
1.38
1.1
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
33
222
1.49
1.38
2.7
2.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
143
1192
1.20
1.38
4.1
4.6
mmol/l
2.4
2.7
0.57
95
820
(40768446) Kidney Pathology biopsy report
27
174
1.55
1.36
2.0
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1730
18049
0.94
1.36
3.9
4.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
43
306
1.41
1.35
4.3
3.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
283
2500
1.14
1.33
1.3
1.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
159
1344
1.19
1.33
1.7
1.5
g/l
0.2
0.2
0.32
150
1268
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
39
274
1.43
1.32
1.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
73
567
1.29
1.32
1.6
1.5
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
39
275
1.42
1.30
1.0
1.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
49
360
1.36
1.29
2.3
2.2
mmol/l
7.6
6.8
0.79
32
239
(3019977) pH of Arterial blood
20
318
0.63
1.28
1.6
2.6
ph
7.4
7.4
—
9
114
(3017354) Segmented neutrophils/100 leukocytes in Blood
72
561
1.29
1.28
2.8
3.6
%
56.9
58.8
0.26
49
349
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
120
992
1.21
1.28
1.2
1.2
mmol/l
3.7
3.9
0.90
111
921
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
12
62
1.94
1.27
1.9
2.2
—
—
—
0
0
(3025315) Body weight
8
35
2.29
1.26
5.1
4.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
77
607
1.27
1.26
1.1
1.3
nmol/l
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
98
795
1.24
1.25
1.2
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
47
346
1.36
1.24
1.3
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
32
220
1.46
1.23
2.7
2.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
32
220
1.46
1.23
2.7
2.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
187
1615
1.16
1.23
1.6
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
12
63
1.91
1.22
1.2
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
12
63
1.91
1.22
1.9
2.2
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
19
2.63
1.21
1.2
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
21
323
0.65
1.18
2.1
1.8
—
—
—
0
0
(3010421) pH of Blood
163
1398
1.17
1.18
4.5
4.4
ph
7.4
7.4
0.15
142
1170
(3011397) Hemoglobin [Presence] in Urine by Test strip
1195
11362
1.07
1.18
3.4
3.8
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
25
165
1.52
1.17
1.7
1.9
e6/l
32799.1
20339.7
0.20
14
98
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
90
731
1.23
1.16
1.3
1.2
u/ml
263.4
287.2
0.39
56
445
(3011648) Oxygen content in Venous blood
52
394
1.32
1.15
1.8
1.9
%
10.5
10.8
0.23
52
394
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
21
321
0.65
1.15
1.4
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
186
1616
1.16
1.15
1.3
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
2425
23538
1.05
1.14
4.8
5.2
estimate
0.0
0.0
0.50
506
4388
(3008898) HLA-B27 [Presence]
102
1231
0.83
1.14
1.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
23
150
1.54
1.14
2.0
2.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
40
292
1.37
1.13
1.9
1.6
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
85
689
1.24
1.12
1.2
1.3
nmol/l
0.2
0.3
0.48
11
42
(3025130) Human papilloma virus identified in Specimen
56
431
1.30
1.12
1.7
1.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
84
681
1.24
1.11
1.2
1.3
nmol/l
0.7
0.6
0.19
78
651
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
315
2839
1.12
1.11
2.5
2.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
327
2957
1.11
1.09
1.8
1.8
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
7
32
2.19
1.08
1.0
1.0
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
26
374
0.69
1.07
1.0
1.0
ng/l
292.9
335.2
0.31
17
250
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
11
59
1.87
1.07
1.2
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
11
59
1.87
1.07
1.2
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
11
59
1.87
1.07
1.2
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
76
613
1.24
1.06
1.4
1.3
pmol/l
295.6
270.5
0.26
57
461
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
104
1240
0.84
1.05
1.5
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
441
4058
1.09
1.04
3.4
2.7
ml/min/173m2
57.9
62.5
1.76
184
1699
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
72
579
1.25
1.04
1.5
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
244
2729
0.89
1.04
3.0
3.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
56
437
1.28
1.03
1.4
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
77
625
1.24
1.03
1.1
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
356
3247
1.10
1.02
2.9
3.1
e9/l
4.1
4.2
0.07
246
2422
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
56
438
1.28
1.02
1.1
1.1
—
40.0
—
0
8
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
14
83
1.69
1.01
1.1
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
10
53
1.89
1.01
1.6
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
203
1795
1.14
1.00
3.3
3.0
g/l
0.3
0.3
0.49
101
740
(1761868) Lipid panel - Serum or Plasma
1535
14770
1.05
1.00
3.0
3.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
109
919
1.19
1.00
1.5
1.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
12
68
1.77
1.00
1.2
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
28
197
1.42
0.99
1.2
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
2415
23503
1.05
0.99
3.6
3.8
estimate
0.0
0.0
0.50
498
4332
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
65
520
1.25
0.99
2.0
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
36
265
1.36
0.99
1.6
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
36
265
1.36
0.99
1.6
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
24
164
1.47
0.99
1.1
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
133
0.53
0.98
1.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
9
49
1.84
0.98
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
44
335
1.32
0.98
1.6
1.7
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
23
2.17
0.98
1.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
14
224
0.62
0.97
1.4
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
59
468
1.26
0.97
2.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
59
468
1.26
0.97
2.1
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
59
468
1.26
0.97
2.1
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
21
140
1.50
0.97
1.6
1.4
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
27
377
0.71
0.96
1.0
1.0
ng/l
36.6
45.5
0.74
18
248
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
19
283
0.67
0.96
2.1
1.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
26
182
1.43
0.95
1.2
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
39
293
1.33
0.95
1.1
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
2446
23831
1.05
0.95
3.7
3.9
estimate
0.0
0.0
1.34
498
4264
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
27
375
0.72
0.94
1.0
1.0
ng/l
500.6
698.6
2.97
16
246
(3000570) Elastase.pancreatic [Mass/mass] in Stool
172
1513
1.14
0.94
1.4
1.4
ug/g
285.7
268.6
0.62
111
909
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
54
426
1.27
0.94
1.6
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
147
1685
0.87
0.93
4.8
4.1
mmol/l
3.9
3.9
0.34
139
1574
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
18
117
1.54
0.93
1.1
1.2
%
77.1
84.1
—
9
63
(3026008) Bacteria identified in Urine by Culture
1622
15662
1.05
0.92
3.1
3.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
9
52
1.73
0.92
1.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
84
698
1.21
0.92
1.1
1.1
—
—
—
0
0
(3000492) Spirometry study
446
4136
1.08
0.91
1.6
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1099
10509
1.06
0.91
1.8
1.8
nmol/l
1160.3
1168.5
0.09
780
7872
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
140
1217
1.15
0.91
1.8
1.7
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
49
619
0.79
0.89
4.3
4.7
umol/l
322.8
349.9
0.61
39
536
(3023487) Leukocytes [#/volume] in Peritoneal fluid
26
185
1.41
0.89
1.7
2.2
e6/l
24913.0
4736.0
0.49
15
136
(3028300) Cannabinoids [Presence] in Urine
58
718
0.81
0.89
3.9
1.8
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
25
347
0.72
0.88
1.1
1.4
promille
2.1
1.1
1.85
17
271
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
10
56
1.79
0.87
2.6
1.9
—
—
—
0
0
(4268621)
54
431
1.26
0.87
2.4
2.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
30
2.00
0.87
1.3
1.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
383
3540
1.09
0.86
3.3
2.7
g/l
10.3
10.6
0.41
342
3221
(3005033) Fetal Nuchal fold Thickness US
39
299
1.31
0.85
1.2
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
58
714
0.81
0.85
3.9
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
40
308
1.30
0.85
1.3
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
63
514
1.23
0.84
1.0
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
53
424
1.25
0.84
1.5
1.6
u/ml
31.8
24.3
0.37
12
93
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
57
460
1.24
0.84
1.1
1.1
—
3.5
—
0
9
(3002032) Base excess in Venous blood by calculation
532
4987
1.07
0.84
4.2
3.7
mmol/l
1.8
2.0
0.55
448
4043
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
19
274
0.69
0.84
1.2
1.4
pmol/l
92.6
160.0
—
5
91
(4034850)
139
1582
0.88
0.83
10.1
10.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
58
711
0.81
0.82
3.9
1.8
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
39
301
1.30
0.82
1.2
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
860
8195
1.06
0.82
1.7
1.5
g/l
2.3
2.6
2.11
483
4855
(3027944) Amphetamines [Presence] in Urine
57
699
0.81
0.82
3.3
1.7
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
137
1202
1.14
0.81
3.5
3.1
nmol/l
0.8
0.8
0.31
111
905
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
31
232
1.34
0.81
1.0
1.1
iu/ml
7.5
11.9
—
7
61
(3043410) Blood group antigens tested for on Red Blood Cells
19
130
1.46
0.80
1.6
1.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
143
1260
1.14
0.80
1.7
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
53
652
0.81
0.79
4.1
1.8
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
6
33
1.82
0.79
1.0
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
140
1233
1.14
0.79
1.6
1.6
e6/l
9726.8
13425.7
0.99
91
884
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
8
48
1.67
0.78
7.9
4.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
17
246
0.69
0.77
1.1
1.2
nmol/l
132.5
137.0
0.23
17
246
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
137
1207
1.14
0.77
1.9
1.9
mg/l
12.2
11.7
0.30
129
1106
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
17
115
1.48
0.76
1.1
1.1
%
77.6
85.5
—
8
60
(4010399)
327
3534
0.92
0.76
1.4
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
229
2082
1.10
0.76
4.2
4.0
mmol/l
24.9
24.9
0.11
206
1889
(3019832) Treponema pallidum Ab [Presence] in Serum
232
2111
1.10
0.76
1.5
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
35
270
1.30
0.75
2.5
2.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
48
386
1.25
0.75
1.3
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
66
550
1.20
0.74
3.5
3.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
132
1164
1.14
0.74
3.5
3.4
u/ml
120.1
762.4
1.91
121
1071
(3042631) Mycobacterium sp identified in Specimen
88
753
1.17
0.74
2.2
2.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
36
280
1.29
0.74
2.6
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
36
280
1.29
0.74
2.5
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
36
280
1.29
0.74
2.6
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
36
280
1.29
0.74
2.6
2.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
25
184
1.36
0.73
1.6
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
416
3889
1.08
0.73
1.6
1.7
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
7
39
1.80
0.72
1.1
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
256
2787
0.91
0.71
1.4
1.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
7
40
1.75
0.71
1.4
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
21
151
1.39
0.71
1.6
1.8
mmol/l
-0.3
0.9
0.75
21
138
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
26
1.92
0.70
2.2
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
247
2265
1.09
0.70
1.8
2.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
75
637
1.18
0.70
1.3
1.2
u/ml
5.4
4.7
0.13
31
267
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
27
1.85
0.68
3.4
3.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
7
42
1.67
0.68
1.0
1.2
u/l
13.3
16.3
—
7
42
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
26
341
0.76
0.68
1.1
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
120
1060
1.13
0.67
1.2
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
20
144
1.39
0.67
3.3
2.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
93
807
1.15
0.67
1.3
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
83
714
1.16
0.67
1.7
1.6
g/l
0.6
0.9
2.04
61
534
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
24
179
1.34
0.66
5.9
1.8
%
143.3
162.4
0.63
24
166
(3004451) EKG impression Narrative
36
285
1.26
0.66
1.3
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
42
339
1.24
0.66
1.4
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
80
688
1.17
0.65
1.7
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
528
5000
1.06
0.65
4.2
3.7
kpa
5.9
5.8
1.13
514
4841
(3004119) Hemoglobin [Mass/volume] in Venous blood
308
3311
0.93
0.65
2.9
3.2
g/l
127.3
128.1
0.23
299
3225
(3037756) Immunofixation for Serum or Plasma
136
1215
1.12
0.65
1.8
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
45
548
0.82
0.64
4.6
1.7
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
17
120
1.42
0.64
1.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
15
212
0.71
0.63
1.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
80
691
1.16
0.63
1.7
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
24
314
0.76
0.62
7.4
2.2
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
15
104
1.44
0.62
1.7
1.5
%
10.3
6.4
—
7
50
(44790049)
66
562
1.18
0.62
1.4
1.4
—
—
—
0
0
(44790047)
66
562
1.18
0.62
1.4
1.4
—
—
—
0
0
(44806118)
66
562
1.18
0.62
1.4
1.4
—
—
—
0
0
(44790048)
66
562
1.18
0.62
1.4
1.4
—
—
—
0
0
(44806420)
12
176
0.68
0.61
2.0
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
164
0.67
0.61
1.8
2.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
164
0.67
0.61
1.8
2.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
145
1307
1.11
0.60
1.9
1.6
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
13
187
0.69
0.60
22.2
15.9
nmol/l
1758.9
1444.7
0.63
13
181
(3014051) Protein [Presence] in Urine by Test strip
131
1175
1.12
0.60
2.0
2.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
15
105
1.43
0.60
1.2
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
51
426
1.20
0.60
1.5
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
40
488
0.82
0.59
1.2
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
195
1787
1.09
0.59
4.2
3.4
ratio
1.4
3.4
1.28
13
139
(3009343) pH of Capillary blood
358
3363
1.07
0.59
3.6
3.7
ph
7.4
7.4
0.12
55
409
(3017315) Amylase [Enzymatic activity/volume] in Urine
18
243
0.74
0.59
1.1
1.2
u/l
436.2
282.1
0.33
18
224
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
28
219
1.28
0.58
1.1
1.2
—
—
—
0
0
(4062490)
54
455
1.19
0.58
1.3
1.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
6
35
1.72
0.57
1.2
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
115
0.61
0.57
6.4
7.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
49
411
1.19
0.56
1.3
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
199
1833
1.09
0.55
4.2
3.4
mg/l
63.7
55.1
0.15
158
1506
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
6
37
1.62
0.55
1.2
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
334
3139
1.07
0.55
1.5
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
97
1092
0.89
0.55
3.2
3.8
mg/l
31.2
28.6
0.23
59
695
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
32
257
1.25
0.55
1.4
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
345
3249
1.07
0.54
3.6
3.7
mmol/l
1.6
1.9
0.61
252
2387
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
6
38
1.58
0.54
1.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
60
1.50
0.54
1.3
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
697
7255
0.96
0.54
1.2
1.2
u/ml
12.7
13.1
0.06
235
2665
(3034860) Kappa light chains.free [Mass/volume] in Serum
199
1836
1.09
0.54
4.3
3.4
mg/l
48.3
90.9
0.77
157
1510
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
182
1673
1.09
0.54
1.5
1.6
titre
105.7
298.7
—
7
77
(40767503) Oxygen content in Capillary blood by calculation
128
1157
1.11
0.53
2.4
2.6
%
15.4
16.0
1.06
74
606
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
15
108
1.39
0.53
1.0
1.4
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
18
134
1.34
0.53
1.2
1.6
ug/l
0.6
0.4
0.77
13
78
(40761535) Cells panel - Urine sediment
415
4374
0.94
0.52
3.7
3.6
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
13
181
0.72
0.52
14.4
11.3
nmol/l
944.8
836.6
0.31
13
170
(3037556) Urate [Mass/volume] in Serum or Plasma
12
169
0.71
0.51
1.4
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
43
511
0.84
0.51
1.1
1.1
u/ml
2.1
3.3
0.59
16
201
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
42
351
1.20
0.51
1.2
1.4
titre
20.0
73.2
—
5
28
(3025468) Yersinia sp identified in Specimen by Organism specific culture
78
688
1.14
0.49
1.7
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
12
84
1.43
0.49
1.3
1.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
66
576
1.15
0.49
1.4
1.4
mmol/l
6.4
6.3
0.05
61
535
(3015183) Erythrocyte sedimentation rate
13
178
0.73
0.48
1.0
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
7
46
1.52
0.48
1.0
1.6
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
7
46
1.52
0.48
1.1
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
28
226
1.24
0.48
1.1
1.1
u/l
1.1
1.1
0.40
16
118
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
360
3413
1.06
0.47
3.6
3.7
kpa
5.1
5.2
1.30
335
3136
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
7
47
1.49
0.47
10.0
4.7
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
94
843
1.12
0.47
1.8
1.9
mmol/l
1.5
1.7
1.64
89
820
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
48
1.46
0.46
1.1
1.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
24
299
0.80
0.46
1.4
1.3
u/ml
0.3
1.2
—
9
150
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
227
2123
1.07
0.46
1.6
1.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
296
2794
1.06
0.46
2.4
1.9
g/l
1.4
1.4
0.09
260
2518
(40765089) Chromosome analysis panel - Blood by G-banded
7
49
1.43
0.46
1.1
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
314
3318
0.94
0.45
2.9
3.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
119
0.67
0.45
3.5
2.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
100
903
1.11
0.45
1.4
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
258
2431
1.06
0.43
4.0
3.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
19
241
0.79
0.43
1.1
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
33
275
1.20
0.43
1.9
1.6
u/l
11.7
6.7
0.35
24
237
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
30
248
1.21
0.42
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
77
688
1.12
0.42
1.8
1.5
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
5
32
1.56
0.42
1.2
1.3
umol/l
0.6
0.8
—
5
20
(3024139) IgG subclass 3 [Mass/volume] in Serum
52
453
1.15
0.41
1.3
1.3
g/l
0.7
0.4
0.51
33
316
(3028192) IgG subclass 2 [Mass/volume] in Serum
52
453
1.15
0.41
1.3
1.3
g/l
2.7
2.9
0.36
33
315
(3027135) IgG subclass 1 [Mass/volume] in Serum
52
453
1.15
0.41
1.3
1.3
g/l
7.9
6.8
0.54
33
316
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
251
2367
1.06
0.41
1.7
1.8
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
22
176
1.25
0.41
1.5
2.1
umol/l
95.4
146.5
0.77
14
101
(3018834) Bilirubin.total [Presence] in Urine by Test strip
5
33
1.52
0.41
3.6
3.8
—
0.0
—
0
5
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.7
—
12.0
—
0
16
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
69
614
1.13
0.41
2.3
2.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
8
59
1.36
0.41
1.1
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
59
1.36
0.41
1.3
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
27
222
1.22
0.41
1.0
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
23
186
1.24
0.40
1.3
2.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
113
1035
1.09
0.40
1.4
1.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
40
465
0.86
0.40
1.1
1.1
u/ml
2.5
3.1
0.21
18
214
(3008401) Mugwort IgE Ab [Units/volume] in Serum
39
453
0.86
0.39
1.0
1.1
u/ml
0.8
1.1
0.29
14
181
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
34
288
1.18
0.39
3.1
2.4
e9/l
0.3
0.2
0.95
29
256
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
51
447
1.14
0.38
1.1
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
80
722
1.11
0.38
1.5
1.5
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
17
133
1.28
0.38
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
123
1332
0.92
0.38
1.6
1.7
mg/l
2.9
3.7
0.60
89
955
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
67
1.34
0.38
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
34
289
1.18
0.37
1.2
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
46
402
1.15
0.37
1.8
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
50
440
1.14
0.36
2.6
2.3
e9/l
0.9
1.1
0.84
27
262
(44816559) Phosphatidylethanol [Mass/volume] in Blood
67
745
0.90
0.36
1.4
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
120
1110
1.08
0.35
2.2
2.6
umol/l
33.7
34.5
0.14
100
938
(3042010) Triglyceride [Moles/volume] in Pleural fluid
12
90
1.33
0.35
1.3
1.2
mmol/l
1.3
1.9
—
7
61
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
63
702
0.90
0.35
1.1
1.1
iu/ml
32.5
1106.1
0.68
12
151
(3025549) Creatine [Moles/time] in 24 hour Urine
6
42
1.43
0.35
1.5
1.4
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
14
108
1.30
0.35
1.8
1.8
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
123
0.73
0.35
1.1
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
26
309
0.84
0.35
1.2
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
35
302
1.16
0.33
3.0
2.4
e6/l
485.0
505.0
0.10
28
257
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
10
133
0.75
0.33
6.1
7.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
298
3116
0.95
0.33
1.2
1.2
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
14
177
0.79
0.33
1.0
1.1
—
3.1
—
0
22
(3020393) Adenovirus Ag [Presence] in Stool
6
46
1.30
0.33
1.2
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
33
284
1.16
0.33
6.6
12.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
177
1668
1.06
0.33
1.6
1.7
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
44
498
0.88
0.32
3.2
3.1
mg/l
12.8
46.5
1.90
32
380
(3039162) Centromere protein B Ab [Units/volume] in Serum
59
530
1.11
0.32
1.2
1.2
—
41.8
—
0
32
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
77
703
1.10
0.32
1.8
1.5
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
21
174
1.21
0.31
2.7
1.9
ug/l
19.4
63.0
0.50
21
161
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
52
1.35
0.31
1.1
2.1
umol/l
13.7
19.6
—
7
52
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
51
456
1.12
0.31
1.2
1.1
%
97.7
95.9
0.16
45
427
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
71
647
1.10
0.31
1.6
1.9
u/l
949.7
3502.4
1.38
19
254
(3024522) Salmonella sp identified in Specimen by Organism specific culture
76
695
1.09
0.31
1.8
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
649
6316
1.03
0.30
6.5
6.9
mmol/l
0.9
1.1
0.75
522
4878
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
55
1.27
0.30
1.3
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
607
5904
1.03
0.30
1.4
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
57
630
0.90
0.29
1.7
1.5
%
50.7
61.0
0.99
34
398
(3040151) Glucose [Moles/volume] in Capillary blood
66
601
1.10
0.29
3.9
18.7
mmol/l
6.6
7.5
1.66
49
504
(3006184) Hemoglobin [Mass/volume] in Capillary blood
131
1229
1.07
0.29
2.0
2.2
g/l
124.5
127.8
0.73
100
875
(3024891) Influenza virus A+B Ag [Presence] in Specimen
120
1123
1.07
0.29
1.2
1.2
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
7
57
1.23
0.29
2.3
1.8
mmol/l
2.6
2.9
—
7
50
(3017704) Immunofixation for Urine
27
313
0.86
0.28
2.1
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
24
204
1.18
0.28
2.7
2.7
—
—
—
0
0
(44813793)
23
270
0.85
0.28
1.0
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
41
364
1.13
0.28
1.2
1.4
titre
1352.0
336.8
—
5
37
(3048879) Bone marrow aspiration report
20
167
1.20
0.28
1.9
1.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
79
729
1.08
0.27
1.4
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
32
280
1.14
0.27
1.5
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
32
280
1.14
0.27
1.5
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
121
1136
1.07
0.27
1.7
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1640
16174
1.02
0.27
3.5
3.2
mmol/l
7.2
7.4
0.56
1342
13428
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
257
2466
1.04
0.27
2.8
2.6
%
0.7
0.7
0.80
249
2359
(3016228) CD19 cells/100 cells in Blood
23
196
1.17
0.27
1.4
2.1
%
10.3
8.4
0.22
23
186
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
71
653
1.09
0.27
1.2
1.2
u/ml
1.5
3.5
2.06
16
205
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
253
2636
0.96
0.26
1.4
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
25
215
1.16
0.26
1.2
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
49
541
0.90
0.26
1.0
1.1
u/ml
0.9
1.9
0.88
19
206
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
49
541
0.90
0.26
1.2
1.3
mmol/l
7.1
7.6
0.56
40
395
(3014891) Appearance of Pleural fluid
11
86
1.28
0.26
2.0
1.5
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
5
72
0.69
0.26
1.4
1.3
nmol/l
10.2
458628.1
—
5
58
(3028433) Virus identified in Specimen by Culture
20
169
1.18
0.25
1.2
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
16
132
1.21
0.25
1.1
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
34
301
1.13
0.25
1.6
1.6
g/l
1.0
0.9
0.17
34
301
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
503
4897
1.03
0.25
2.3
3.0
ng/l
243.3
214.3
0.64
448
4483
(3037522) Nuclear Ab [Titer] in Serum
614
5995
1.03
0.25
1.4
1.3
titre
538.9
497.4
0.22
129
1283
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
37
330
1.12
0.25
1.9
2.0
%
17.4
14.7
0.39
14
136
(3028626) Oxygen [Partial pressure] in Capillary blood
114
1210
0.94
0.24
2.4
2.9
kpa
8.0
7.9
0.17
103
1123
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
101
947
1.07
0.24
1.2
1.2
—
9.6
—
0
12
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
51
465
1.10
0.24
1.1
1.3
nmol/l
1.3
1.5
0.93
44
419
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
98
920
1.07
0.23
1.2
1.2
u/ml
6.8
5.3
—
5
68
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
38
1.32
0.23
1.6
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
649
6352
1.02
0.23
6.5
6.9
kpa
12.6
12.1
1.57
621
6041
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
649
6353
1.02
0.22
6.5
6.9
kpa
5.1
5.1
0.16
621
6043
(3002523) Influenza virus A Ag [Presence] in Specimen
53
486
1.09
0.22
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
53
486
1.09
0.22
1.1
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
15
125
1.20
0.22
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
15
125
1.20
0.22
1.1
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
14
116
1.21
0.22
1.7
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1594
15753
1.02
0.22
3.5
3.2
mg/l
377.2
345.1
0.10
991
9992
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
34
305
1.12
0.21
1.5
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
28
248
1.13
0.21
4.0
3.7
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
42
1.19
0.21
1.0
2.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
166
1734
0.96
0.21
1.2
1.2
u/ml
0.4
1.2
1.97
12
165
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
10
0.00
0.21
0.0
5.6
—
50.4
—
0
10
(3020874) Milk IgE Ab [Units/volume] in Serum
13
156
0.83
0.21
1.1
1.0
u/ml
0.3
0.9
—
5
50
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
21
241
0.87
0.21
1.4
1.3
mmol/l
5.9
6.1
0.25
21
228
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
60
556
1.08
0.21
3.2
3.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
12
145
0.83
0.21
1.5
1.1
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.3
—
2.1
—
0
13
(4281824)
55
508
1.08
0.20
1.2
1.2
—
—
—
0
0
(4146454)
65
605
1.08
0.20
2.7
2.7
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
14
117
1.20
0.20
1.3
1.2
mmol/l
1.2
1.7
—
7
74
(42529582) MDA5 Ab [Presence] in Serum by Line blot
10
123
0.81
0.20
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
10
123
0.81
0.20
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
10
123
0.81
0.20
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
10
123
0.81
0.20
1.0
1.1
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
3.9
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
117
1112
1.05
0.20
1.3
1.2
u/ml
2.1
5.7
—
7
114
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
20
229
0.87
0.20
6.3
5.3
u/ml
788.0
54.7
—
5
43
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
9
115
0.78
0.20
1.3
1.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
15
127
1.18
0.19
1.1
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
15
127
1.18
0.19
1.4
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
51
1.18
0.19
2.2
2.4
u/field
0.5
0.6
—
6
51
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
21
239
0.88
0.19
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
30
333
0.90
0.19
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
53
491
1.08
0.19
1.2
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
19
165
1.15
0.19
1.3
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
52
1.15
0.19
1.0
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
48
443
1.08
0.19
2.6
2.2
ml
631.4
645.6
0.11
33
286
(3016502) Oxygen saturation in Arterial blood
559
5700
0.98
0.18
7.1
7.2
%
96.1
95.5
2.80
540
5481
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
118
1126
1.05
0.18
1.3
1.2
u/ml
5.1
7.1
0.30
13
188
(3034274) Bile acid [Moles/volume] in Serum --fasting
26
290
0.90
0.18
1.6
1.6
umol/l
9.8
9.5
0.02
18
196
(3005011) Chlamydia sp Ab [Titer] in Serum
7
60
1.17
0.17
1.6
1.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
419
4097
1.02
0.17
3.2
3.1
kpa
4.7
4.5
0.66
403
3951
(3035320) C reactive protein [Mass/volume] in Body fluid
37
339
1.09
0.17
2.9
2.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
12
101
1.19
0.16
1.0
1.2
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
37
340
1.09
0.16
1.9
2.0
%
66.9
72.1
0.84
37
317
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
8
69
1.16
0.16
1.3
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
29
263
1.10
0.16
4.6
3.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
71
1.13
0.16
1.3
1.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
21
187
1.12
0.15
1.1
1.1
ng/l
88.8
482.1
—
5
50
(4015189)
13
151
0.86
0.15
1.7
2.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
29
318
0.91
0.15
1.0
1.1
u/ml
1.6
2.3
—
10
123
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
125
1201
1.04
0.15
1.3
1.2
u/ml
67.9
37.8
—
5
69
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
6
78
0.77
0.15
1.0
1.1
—
5.1
—
0
8
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
83
1.21
0.15
1.2
1.6
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
46
493
0.93
0.15
1.3
1.3
e6/l
104672.2
106492.9
0.01
39
336
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
74
780
0.95
0.15
1.2
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
227
2334
0.97
0.15
1.8
1.9
ug/l
1.9
2.5
0.34
191
2039
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
259
2524
1.03
0.15
2.8
2.6
%
1.2
1.2
0.22
259
2509
(3024263) Appearance of Synovial fluid
31
284
1.09
0.15
2.0
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
129
1339
0.96
0.14
2.6
2.3
ug/min
68.9
103.9
0.86
82
792
(4306422)
65
615
1.06
0.14
1.3
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
17
150
1.13
0.14
1.1
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
65
686
0.95
0.14
1.4
1.6
—
—
—
0
0
(3024471) HLA-A [Type]
15
131
1.15
0.14
1.0
1.0
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
22
198
1.11
0.14
1.6
1.5
%
3.0
2.6
0.06
16
163
(3035947) Staphylolysin Ab [Units/volume] in Serum
23
254
0.91
0.14
1.0
1.1
—
4.3
—
0
11
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
82
782
1.05
0.14
1.7
1.9
pmol/l
191.4
198.8
0.30
74
734
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
89
851
1.05
0.14
1.2
1.2
u/ml
40.3
42.2
—
7
92
(4094501)
138
1333
1.04
0.14
1.1
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
8
99
0.81
0.13
3.3
2.8
u/l
81.4
1820.5
—
8
94
(3051101) Glucose [Moles/volume] in Cord blood
8
99
0.81
0.13
6.4
6.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
506
4979
1.02
0.13
2.3
2.4
ug/l
7.5
7.0
0.21
429
4301
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
13
149
0.87
0.13
1.3
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
469
4613
1.02
0.13
1.5
1.7
%
1.6
1.5
0.28
395
3971
(3002173) Hemoglobin [Mass/volume] in Arterial blood
515
5231
0.98
0.13
7.5
7.7
g/l
120.3
120.6
0.11
500
5035
(3042111) Morphology [Interpretation] in Bone marrow Narrative
101
971
1.04
0.13
1.4
1.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
10
117
0.85
0.13
1.1
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
934
9241
1.01
0.13
1.3
1.2
u/ml
1.6
1.9
0.35
220
2357
(3039443) Prostate specific Ag panel - Serum or Plasma
78
815
0.96
0.12
1.8
1.6
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
275
2809
0.98
0.12
2.7
2.9
e6/l
0.3
0.3
0.49
269
2749
(3003181) Sodium [Moles/volume] in Urine
98
943
1.04
0.12
1.3
1.3
mmol/l
62.3
63.2
0.07
81
771
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
198
1930
1.03
0.12
1.5
1.5
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
18
162
1.11
0.11
1.4
1.2
g/l
36.6
39.6
0.41
11
81
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
78
813
0.96
0.11
1.3
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
88
847
1.04
0.11
1.1
1.3
miu/ml
215.7
209.4
0.05
36
353
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
98
946
1.04
0.11
1.9
1.7
nmol/l
0.8
0.8
0.08
83
786
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
31
289
1.07
0.11
2.2
2.1
ug/min
8.0
195.5
—
5
75
(3027923) C peptide [Moles/volume] in Serum or Plasma
25
270
0.93
0.10
1.5
1.3
nmol/l
1.1
1.2
0.25
14
208
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
13
115
1.13
0.10
2.1
2.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
16
144
1.11
0.10
1.3
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
69
718
0.96
0.10
1.2
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
46
437
1.05
0.10
1.5
2.1
u/field
2.8
1.9
0.35
19
165
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
757
7643
0.99
0.10
1.3
1.3
iu/ml
32.2
35.2
0.30
208
2333
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
71
683
1.04
0.10
1.3
1.6
—
—
—
0
0
(4211845)
29
271
1.07
0.09
3.9
3.6
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
46
483
0.95
0.09
1.1
1.1
—
2.7
—
0
11
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
28
262
1.07
0.09
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
67
645
1.04
0.09
1.3
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
124
0.89
0.09
1.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
25
268
0.93
0.09
1.0
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
135
1383
0.98
0.09
4.9
3.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
60
624
0.96
0.09
1.1
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
6
55
1.09
0.08
1.0
1.1
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
26
243
1.07
0.08
1.6
1.5
%
59.8
65.9
0.40
20
194
(3020682) Albumin/Creatinine [Ratio] in Urine
1669
16605
1.01
0.08
4.3
4.0
mg/mmol
7.6
9.3
0.95
1018
10486
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
57
1.05
0.08
1.5
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
50
479
1.04
0.08
1.7
1.4
%
40.8
28.5
1.16
30
295
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
85
876
0.97
0.08
1.7
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
331
3354
0.99
0.08
1.2
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
348
0.95
0.08
1.2
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
33
348
0.95
0.08
1.0
1.1
u/ml
0.6
2.2
—
9
131
(4133840)
11
98
1.12
0.07
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
25
266
0.94
0.07
1.0
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
75
0.80
0.07
1.5
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
55
570
0.96
0.07
1.5
1.3
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
11
122
0.90
0.07
1.5
1.6
mmol/l
8.0
8.7
—
5
76
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
8
92
0.87
0.06
1.6
1.5
ng/l
109.6
134.4
—
8
92
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
99
1.11
0.06
2.3
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
9
101
0.89
0.06
1.2
1.7
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
13
142
0.92
0.06
1.2
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1294
12880
1.01
0.06
4.1
4.3
estimate
0.0
0.0
1.08
478
4199
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
14
152
0.92
0.06
1.0
1.1
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
14
152
0.92
0.06
2.8
2.0
%
35.2
30.2
0.47
14
139
(3052592) Norovirus Ag [Presence] in Stool
12
109
1.10
0.06
1.1
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
12
109
1.10
0.06
1.8
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
13
119
1.09
0.06
1.6
1.7
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
13
119
1.09
0.06
1.5
1.3
mu/l
47.5
63.5
0.23
13
90
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
35
365
0.96
0.06
1.4
1.2
titre
145.0
143.4
—
6
62
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
14
129
1.09
0.05
1.1
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
144
1417
1.02
0.05
2.5
3.2
mmol/l
24.5
25.0
0.60
126
1227
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
17
159
1.07
0.05
1.6
2.0
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
13
120
1.08
0.04
1.5
2.4
mmol/l
7.8
7.6
—
8
72
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
37
357
1.04
0.04
1.1
1.0
mg/l
290.0
289.4
0.02
32
317
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
199
2013
0.99
0.04
1.0
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
26
272
0.96
0.04
1.7
1.7
u/field
2.5
2.3
0.06
19
195
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
27
282
0.96
0.04
3.1
3.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
301
2984
1.01
0.04
8.9
9.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
138
1361
1.01
0.04
1.9
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
45
463
0.97
0.04
6.9
2.7
—
—
—
0
0
(4024509)
52
533
0.98
0.04
1.4
1.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
55
563
0.98
0.03
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
21
220
0.95
0.03
1.4
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1231
12345
1.00
0.03
3.5
3.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
39
379
1.03
0.03
1.4
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
41
399
1.03
0.03
1.1
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
12
112
1.07
0.03
1.3
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
11
118
0.93
0.02
1.5
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
14
132
1.06
0.02
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
15
142
1.06
0.02
1.0
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
16
152
1.05
0.02
1.2
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3826
38237
1.00
0.02
24.6
20.9
g/l
331.5
331.8
1.31
3804
37908
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
140
1411
0.99
0.02
1.4
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
89
899
0.99
0.01
1.2
1.3
u/l
106.5
36.0
1.16
79
774
(3021901) Oxygen saturation in Capillary blood
103
1039
0.99
0.01
2.3
2.9
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
100
992
1.01
0.01
1.2
1.2
—
242.7
—
0
22
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
39
397
0.98
0.01
1.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
117
1162
1.01
0.01
1.6
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
86
853
1.01
0.01
1.5
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
11
104
1.06
0.01
2.6
2.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
11
104
1.06
0.01
1.4
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
10
106
0.94
0.01
1.3
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
12
126
0.95
0.00
1.2
1.5
ug/l
7.1
8.9
2.03
12
126
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
18
174
1.03
0.00
2.4
1.8
ug/l
54.9
53.1
0.07
18
169
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
10
98
1.02
0.00
1.1
1.1
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
15
152
0.99
0.00
2.7
2.0
%
10.8
9.6
0.09
15
135
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
16
158
1.01
0.00
1.1
1.1
miu/ml
1504.9
1617.3
0.14
16
158
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
12
125
0.96
0.00
1.2
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
40
402
0.99
0.00
1.0
1.1
u/ml
0.1
1.6
—
8
96
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
43
432
1.00
0.00
1.4
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
24
235
1.02
0.00
1.8
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
31
305
1.02
0.00
1.2
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
31
305
1.02
0.00
1.2
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
82
818
1.00
0.00
1.3
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
58
575
1.01
0.00
1.5
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
59
595
0.99
0.00
1.2
1.1
%
125.4
115.5
1.57
53
529
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
136
1355
1.00
0.00
1.6
1.6
iu/ml
0.1
7.3
0.97
28
302
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
13
126
1.03
0.00
1.2
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
15
146
1.03
0.00
1.1
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
16
164
0.98
0.00
1.1
1.0
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
35
346
1.01
0.00
1.1
1.1
mmol/l
28.9
35.0
1.25
28
298
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
32
323
0.99
0.00
2.6
2.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
39
387
1.01
0.00
1.5
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
28
281
1.00
0.00
1.0
1.0
u/ml
0.1
0.3
—
7
79
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
37
371
1.00
0.00
1.3
1.1
—
76.5
—
0
15
(3020891) Body temperature
221
2211
1.00
0.00
5.0
4.7
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
25.8
—
0
5
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
58
0.86
0.00
1.2
1.4
umol/l
43.0
41.9
—
5
58
(3008343) Lysozyme [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
0.5
—
0
5
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
5
54
0.93
0.00
11.0
1.9
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
9
94
0.96
0.00
1.4
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
10
100
1.00
0.00
1.7
3.4
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
1.6
—
0
9
(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
39.0
—
0
6
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
8
81
0.99
0.00
1.3
1.1
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
109.3
—
0
8
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
51
0.98
0.00
1.0
1.3
umol/24h
2.2
1.8
—
5
51
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
69
0.87
0.00
1.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
79
0.89
0.00
1.0
1.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
9
0.00
0.00
0.0
1.3
—
2897.8
—
0
9

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_MELANOMA – Malignant melanoma

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).